Update: April, 2001 · 2009 Outstanding Service Award, International Union Against Tuberculosis and...

CURRENT TO: March 7, 2017

CV: Dr. Richard Long

CURRICULUM VITAE

RICHARD LONG, MD I PERSONAL INFORMATION

Citizenship: Canadian

Address: Work: University of Alberta Hospitals 8325 Aberhart Centre 1 University of Alberta Edmonton, Alberta T6G 2J3 Tel: (780) 407-1427 Fax: (780) 407-1429 E-mail: [email protected]

Web Site: http://tbper.ualberta.ca Web Site: http://prg.ualberta.ca

II PRESENT ACADEMIC RANK AND POSITION

Professor University of Alberta, Department of Medicine

Adjunct Professor School of Public Health, University of Alberta

Member Pulmonary Division, Department of Medicine, University of Alberta, Edmonton, Alberta

Director Tuberculosis Program Evaluation and Research Unit, University of Alberta, Edmonton

Tuberculosis Consultant Northwest Territories

Attending Physician, Edmonton TB Clinic, Edmonton Zone, Alberta

Tuberculosis

Attending Physician, TB Inpatient Unit, Walter Mackenzie Centre, University of Alberta Hospital

Tuberculosis

mailto:[email protected]

http://tbper.ualberta.ca/

http://prg.ualberta.ca/

CV: Richard Long

III EDUCATION

Undergraduate:

1964 - 1967 Bachelor of Science BSc

University of Manitoba and United College, Winnipeg Major: Mathematics

1967 - 1971 Medicine MD

University of Manitoba

Postgraduate: 1971 - 1972 Rotating Internship

Health Sciences Centre, Winnipeg 1972 - 1973 General Surgery

University of British Columbia, Vancouver General Hospital

1973 - 1976 General Practice

Vancouver, British Columbia 1976 - 1980 Residency Internal Medicine, University of Manitoba 1980 - 1982 Fellowship Critical Care Medicine FRCP(C)

Department of Medicine University of Manitoba Respiratory Investigation Unit Health Sciences Centre, Winnipeg Supervisors: L.D.H. Wood and L. Oppenhiemer

1982 - 1984 Research Associate

Section of Pulmonary & Critical Care University of Chicago Supervisor: L.D.H. Wood

1984 - 1986 Fellowship, Respiratory Medicine

Section of Respirology University of Manitoba Health Sciences Centre, Winnipeg FCCP Supervisor: N. Anthonisen

IV MEDICAL LICENSURE

Province of Alberta, Canada Past Licensure: Province of British Columbia, Canada State of Illinois, USA Province of Manitoba, Canada

CV: Richard Long

V POSTGRADUATE HONORS/AWARDS

1988 - 1989 "A" Service Medicine, St. Boniface Hospital; most outstanding rotation, Medicine IV.

1989 - 1990 Honourable Mention, most outstanding Clinician,

Medicine IV.

1990 - 1991 Most outstanding Clinician, Medicine IV.

1993 - 1994 Educator of the Year Professional Association of Residents and Interns of Manitoba

1995 Outstanding Contributor to the Educational Program of Respiratory

Department of Medicine, University of Manitoba

2003 Alberta Lung Association, Medical and Scientific Section Award of Excellence

2004 Alberta Health and Wellness REACH Team Award

2009 Outstanding Service Award, International Union Against Tuberculosis and Lung Disease, North American Region

2014 Norman L. Jones Award for best paper in the Canadian Respiratory Journal in 2013

2014 2014 Canadian Thoracic Society (CTS) Honorary Lecture Award. CTS Scientific Program, American College of Chest Physician Annual CHEST Conference. Austin, Texas, October 27, 2014

VI PREVIOUS PROFESSIONAL POSITIONS AND APPOINTMENTS

1980 - 1984

Research Associate, Respirology Section and Critical Care Section, Department of Medicine, University of Manitoba (2 years) and University of Chicago (2 years) April 1988 - July 1991

Chief "A" Service Medicine, St. Boniface General Hospital, Winnipeg - Intensivist, Medical and Surgical Intensive Care Unit, St. Boniface General Hospital - Consultant in Respirology, St. Boniface General Hospital - Assistant Professor, University of Manitoba, Winnipeg MB

1991 - 1997

Program Director, Respirology Section, University of Manitoba - Consultant in Respirology, Health Sciences Centre and St. Boniface General Hospital - Intensivist, Medical and Surgical Intensive Care, St. Boniface General Hospital - Associate Professor, University of Manitoba, Winnipeg MB

1998 - 2008 (June 30)

Provincial Medical Consultant, Tuberculosis, Alberta Health and Wellness, Provincial Health Office, Edmonton, Alberta

CV: Richard Long

2009 - 2015

Tuberculosis Consultant, First Nations and Inuit Health Branch, Health Canada 2015-2017

Tuberculosis Consultant, Northwest Territories

VII EDUCATIONAL ACTIVITIES

Teaching Curriculum Vitae available upon request

VIII EDUCATION - JOURNALS

Scientific reviewer for peer-reviewed medical journals

IX CURRENT INSTITUTIONAL/DEPARTMENTAL AND DIVISIONAL COMMITTEE

MEMBERSHIPS (University of Alberta)

1998 - Member, The Canadian Thoracic Society Tuberculosis Committee (Past Chair, 1997-06) 1998 - 2009 Member, CTC Subcommittee on Immigration 1998 - Member, ALA Medical and Scientific Section 1998 - Tuberculosis Control / First Nations and Inuit Health Tuberculosis Planning Committee 1998 - Member/Past chair, Tuberculosis Control Committee of Alberta (TBCCA) 1998 - Member, Provincial Laboratory for Public Health TB Committee 1998 - Member, Pulmonary Research Group, University of Alberta 1998 - 2008 Committee of Medical Officers of Health (COMOSH) of Alberta 1998 - 2011 Member/Past Chair, Canadian Tuberculosis Committee 2000 - Member, Committee of the Tuberculosis In-Patient Unit and Edmonton TB Clinic 2002 - 2008 Member, CTC Subcommittee on Research 2002 - 2008 Member, BCG Working Group; Centre for Infectious Disease Prevention and Control and

First Nations and Inuit Health Branch, Health Canada 2004 - 2008 Member, CTC Subcommittee on Surveillance (Past Chair, 2005-06) 2004 - 2008 Member, Canadian Genotyping Reference Database Working Group 2006 - 2008 Member, CTC Subcommittee on Metropolitan TB Issues 2007 - 2008 Member, Westpark Healthcare Centre Working Group 2008 - 2011 Member, CTC Aboriginal Scientific Subcommittee 2009 - 2016 Member, First Nations and Inuit Health Branch National Strategy Working Group 2010 - 2014 Member, Inter-provincial TB Working Group 2011 - 2013 Senior Editorial Group, 7th Edition, Canadian Tuberculosis Standards 2011 - 2013 Acting Chair, ‘Canadian Tuberculosis Committee’ in transition 2012 - 2014 Member, Tuberculosis Task Group, Centre for Communicable Disease and Infection

Control, PHAC 2013 - Member, Nunavut TB Advisory Committee 2014 - 2016 Member, Interprovincial TB Working Group (Past Chair 2014-2015) 2014 - Member, TBCCA Subcommittee on TB Program Performance Indicators 2014 - Member, Planning Committee CTS-PHAC Educational Modules for TB 2015 - Member, STOP TB Canada 2015 - Co-chair and member, Canadian Tuberculosis Elimination Network 2016 - Member, Advisory Group for the Manitoba Centre for Health Policy deliverable

“Tuberculosis treatment, prevention and management in Manitoba”

CV: Richard Long

X GRANT REVIEW COMMITTEES NEAHR – Network Environments for Aboriginal Health Research; CIHR – Planning and Dissemination Grants; CIHR – Population and Public Health Grants; UHF – University Hospital Foundation Grants

XI PROFESSIONAL MEMBERSHIPS AND SOCIETIES 1. Alberta Medical Association/Canadian Medical Association 2. College of Physicians and Surgeons of Alberta 3. Alberta Lung Association, Medical and Scientific Section 4. Capital Region Medical Staff Association 5. Canadian Thoracic Society 6. American Thoracic Society 7. International Union Against Tuberculosis and Lung Disease 8. International Union Against Tuberculosis and Lung Disease, North American Region 9. Hôpital Albert Schweitzer Alumni Association

XII EXTRAORDINARY PROFESSIONAL ACTIVITIES (Voluntary) 1. Volunteer Internist/Pulmonologist/tuberculosis consultant, Department of Medicine, Hôpital Albert

Schweitzer, Haiti. 2. External consultant, Tuberculosis Control, Atlantic Canada. 3. External consultant, Tuberculosis Control, Northwest Territories, 1998-2015

4. Member TB Task Group, CCDIC, PHAC

XIII FORMAL MENTORING

1. Dr. Gabor Gyenes, MD, PhD, Division of Cardiology, Department of Medicine, University of Alberta.

2. Dr. Alex Doroshenko MD, MPH, FFPH (UK), FRCP(c), Division of Preventive Medicine, Department of Medicine, University of Alberta.

3. Dr. Meghan Leitch, MD, FRCP(C), General Internal Medicine. Stanton Hospital, Yellowknife, NWT.

XIV INVITED TALKS AND PRESENTATIONS, as a University of Alberta faculty member

CV: Richard Long

1. Medical Grand Rounds. University of Alberta. “Pulmonary Tuberculosis Treated with Directly Observed Therapy: Serial Changes in Lung Structure and Function”. 1998.

2. The Northern Alberta Institute of Technology. “Tuberculosis for Respiratory Therapists”. March 18, 1998.

3. Alberta Justice. “Tuberculosis in Correctional Facilities”. May 21, 1998.

4. Respiratory Therapy Education Day. Edmonton Inn. New Developments in Tuberculosis, June 3, 1998.

5. Fourth Annual Respiratory Roundup. Alberta Lung Association. New Developments in Tuberculosis. June 19, 1998.

6. Nursing Grand Rounds: Infection Control Week. Royal Alexandra Hospital, Edmonton. October 13, 1998.

7. Fifth Annual Alberta Respiratory Disease Symposium. Alberta Lung Association. Chairperson, Section on Lung Infections; Tuberculosis Elimination. October 17, 1998.

8. Saskatchewan Thoracic Society. Saskatoon, Saskatchewan. Multidrug-resistant Tuberculosis. November 6, 1998.

9. Medical Grand Rounds. Fort McMurray, Alberta. Pulmonary tuberculosis and the recent outbreak on the Janvier Reserve. February 2, 1999.

10. Tuberculosis Conference (Tuberculosis Coming to a Community Near You). Edmonton, Alberta. Multidrug-resistant tuberculosis and new treatments. March 19, 1999.

11. The University of Alberta, Tenth Annual Resident Research Day. Multidrug-resistant tuberculosis in Alberta and British Columbia, 1989-98. Presenter: Ahmad Hersi; Supervisor: Richard Long. May 6, 1999.

12. Medical Grand Rounds. University of Alberta. What’s new, What’s hot. “Drug-resistant tuberculosis”. April 28, 1999.

13. Medical Grand Rounds. Misericordia Hospital, Edmonton, AB. Pulmonary Tuberculosis: making a timely diagnosis. June 17, 1999.

14. Medical Grand Rounds. Grey Nuns Hospital, Edmonton, AB. Pulmonary Tuberculosis: making a timely diagnosis. June 23, 1999.

15. Medical Grand Rounds. University of Alberta Hospitals, Edmonton, AB. Treatment of sputum smear-positive pulmonary tuberculosis with inhaled nitric oxide. September 3, 1999.

16. City Wide Emergency Rounds. St. Boniface Hospital Research Centre, Winnipeg, Manitoba. “Tuberculosis in the Emergency Room: Danger and Opportunity”. October 20, 1999.

17. TB Interest Group, Capital Health Region. “TB in the Emergency Room”. November 17, 1999.

18. Emergency Regional Core Committee. “TB in the Emergency Room”. November 18, 1999.

CV: Richard Long

19. Medical Grand Rounds. Wetaskiwin Hospital and Health Centre, Crossroads Health Region, AB. Tuberculosis in Alberta; making a timely diagnosis. November 24, 1999.

20. Stoney Health Centre, Headwaters Region, Alberta. “Tuberculosis in Alberta”. April 12, 2000.

21. Standoff Health Centre, Chinook Region, Alberta, “Tuberculosis in Alberta”. May 3, 2000.

22. Alberta Justice. ‘Short-course’ Treatment of Latent Tuberculous Infection in Correctional Institutions. June 1, 2000.

23. Annual Joint Meeting of Alberta Infection Control Practitioners (NAPic-Northern Alberta

Practitioners in Infection Control, and CAPic - Calgary and area Practitioners in Infection

Control) “Tuberculosis in the Emergency Room”, Red Deer, October 4th, 2000.

24. Council of Medical Officers of Health (CoMOsH) “Tuberculosis in the Emergency Room”, Edmonton, October 13th, 2000.

25. Tuberculosis Workshop for Nurses (Tuberculosis Control, Saskatchewan). “Drug-Resistant Tuberculosis”, Saskatoon, February 7, 2001.

26. Tuberculosis, Forging the Streams. Edmonton, Alberta, March 22 and 23, 2001 a. “TB in Alberta. Issues, Vision, Direction.” b. “Turn the Light Bulb On in Your Emergency Room.” (with Michele Zielinski, BScN) c. “Forging the Streams, Future Directions.”

27. Grand Rounds, Hôpital Albert Schweitzer, Haiti. “Drug Resistant Tuberculosis.” April 26, 2001.

28. Educational Half-Day in Honour of Dr. Leo Kahana, McMaster University. “Drug-Resistant Tuberculosis.” May 8, 2001

29. Canmore Hospital, CME. “Tuberculosis in the Emergency Department: Diagnostic Considerations”, November 15, 2001.

30. Medicine Hat Regional Hospital. Grand Rounds. “Making a Timely Diagnosis of Tuberculosis”, November 30, 2001.

31. 2001: A TB Odyssey. Toronto, Ontario, December 5 & 6, 2001.

“Canadian Tuberculosis Standards, What’s New”

“Drug-Resistant Tuberculosis”

32. Department of Medicine “Bench-to-Bedside Research in Progress” University of Alberta. “Treatment of sputum smear-positive pulmonary tuberculosis with inhaled nitric oxide”, Edmonton, January 22, 2002.

33. Medical Services Branch Citizenship and Immigration, Canada Conference 2002. “Come Together”, Tuberculosis Seminar, Ottawa, January 30, 2002.

34. 2nd Annual Alberta Respiratory Disease Symposium. “Tuberculosis in the foreign-born” plenary session, Banff, April 19, 2002.

35. 6th Annual Conference, Alberta Association of Travel Health Professionals. “Tuberculosis in returning travelers”, Calgary, AB, June 7, 2002.

CV: Richard Long

36. Provincial Laboratory for Public Health (Microbiology). Technology and Research Symposium

2002. “The PLPH and Tuberculosis Surveillance”, Calgary, October 18, 2002.

37. Canadian Association of Cardio-pulmonary Technologists, Canadian Cardiovascular Congress. “Tuberculosis and Related Issues”, Edmonton, October 28, 2002.

38. Rocky Mountain General Internal Medicine Conference. “Tuberculosis in 2002” (Keynote address), Banff, November 14, 2002.

39. 4th Biannual Spring Conference. “Tuberculosis: Elimination or Resurgence”, Edmonton, March 17-18, 2003.

a. “Introduction to the current trends in tuberculosis and threats to tuberculosis control.” b. “Who needs tuberculin testing? New approaches.”

40. Workshop on Strengthening the Tuberculosis Control Program, First Nations and Inuit Health Branch, Health Canada. “Provincial Tuberculosis Directors Recommendations”, Ottawa, April 7-9, 2003.

41. Northern Lights Regional Hospital, “Tuberculosis Control in Northern Alberta”, July 10, 2003.

42. University Hospital Foundation Health Talks, “Tuberculosis Research in Alberta”, October 25, 2003.

43. Thoracic Program Development Retreat, University of Alberta, “Management of Tuberculosis”, November 15, 2003.

44. Alberta Health and Wellness, BCG Working Group, “Statement from the Ad-Hoc Committee on the Future of BCG Vaccination in First Nations Communities”, December 1, 2003.

45. Medical Grand Rounds, Department of Medicine, University of Alberta, “Tuberculosis in the Foreign-born in Alberta”, December 12, 2003.

46. First Nations and Inuit Health TB Nurses. "Statement from the Ad-Hoc Committee on the Future of BCG Vaccination in First Nations Communities". Edmonton, February 10, 2004.

47. First Nations and Inuit Health TB Nurses. "Statement from the Ad-Hoc Committee on the Future of BCG Vaccination in First Nations Communities". Calgary, February 24, 2004.

48. First Nations and Inuit Health TB Nurses. "Statement from the Ad-Hoc Committee on the Future of BCG Vaccination in First Nations Communities". St. Paul, Alberta, March 4, 2004.

49. Grand Rounds, Hôpital Albert Schweitzer, Haiti. "The whole blood interferon gamma release assay", July 12, 2004.

50. FNIHB and Band Nurses Professional Development. "Communicable Diseases….The

Alberta Picture. "Tuberculosis Management in Alberta", Fantasyland Hotel, November 23, 2004.

51. FNIHB and Band Nurses Professional Development. "Communicable Diseases…The

Alberta Picture. Tuberculosis Management in Alberta. Fantasyland Hotel, January 11, 2004.

52. Alberta TB Nurses Working Group. "CSI Alberta", Edmonton, January 28, 2005.

53. World TB Day Videoconference. "CSI Alberta", Edmonton, March 24, 2005.

54. Global Lung Health Symposium, University of Alberta. "Impact of the Global TB Burden in

Canada". University of Alberta, March 4, 2005.

CV: Richard Long

55. Grand Rounds, Department of Medicine, University of Manitoba. Tuberculosis in Prairie First Nations: New Insights Into An Old Foe, Winnipeg, Manitoba, May 10, 2005.

56. Aboriginal Health Workshop on Indoor Air Quality, Housing and Lung Health. “TB and How it’s Transmitted”. Edmonton, October 11, 2005.

57. Grand Rounds, Department of Pediatrics, University of Alberta. “The Conventional and Molecular Epidemiology of Pediatric Tuberculosis in Alberta (1990-2004)”. University of Alberta, December 1, 2005.

58. Alberta TB Nurses Working Group. “TB in Immigrants to Alberta”. Edmonton, January 27, 2006.

59. NWT STOP-TB Conference. (1) “BCG vaccination in the Canadian North, Pros and Cons. (2) TB Case Scenarios, Questions and Answers. Yellowknife, NWT, February 2, 2006.

60. TB Conference for Nurses, Saskatoon, Saskatchewan. “The Epidemiology of TB on the Prairies”. Saskatoon, Saskatchewan, February 9, 2006.

61. Canadian Tuberculosis Laboratory Technicians Network (CTLTN). “CTLTN Update from the CTC/CTS”. Victoria, BC, March 14, 2006.

62. Fifth Spring Conference on Tuberculosis. The Edge of Change: What’s new in an old

disease. Edmonton, March 23-24, 2006.

a. Introduction and Statistics b. BCG changes c. Technologies finest hour: Leading the edge of change d. Pediatric TB in Alberta e. Changes on the Horizon – HIV/TB, MDR-TB

63. Alberta Health and Wellness, “The Citizenship and Immigration (CIC) Medical Surveillance Referral Process”, Provincial Health Office, Edmonton, June 28, 2006

64. The Lung Association Tuberculosis Conference. The Face of TB. “What’s New in the Canadian TB Standards, 6th Edition”. Toronto, November 20, 2006.

65. The Provincial Health Office and the TB control Committee of Alberta, “TB and HIV Co-morbidity in Alberta, 1991-2006”. February 28, 2007 and March 16, 2007, respectively Edmonton.

66. The TB Control Committee of Alberta and the Immigration Subcommittee of the Canadian

Tuberculosis Committee, “TB in International Adopties”. March 6, 2007 and April 26, 2007, respectively. Edmonton.

67. East Central Health Region, “The Changing Face of TB in Alberta”. Camrose, September 6, 2007

68. The TB Nurses Working Group and the TB Control Committee of Alberta, “Fast-tracking preventive therapy starts in TB contacts that are young or immunocompromized”. June 22, 2007 and October 22, 2007, respectively.

69. Student Health Department, University of Alberta, “Detection and Treatment of Latent Tuberculosis Infection in Foreign-born Students of Healthcare Professions”. Edmonton, November 13, 2007.

70. Family Practice Rounds, Misericordia Hospital, “TB 101 for Family Physicians”, Edmonton, AB, February 21, 2008.

71. 6th TB Conference 2008, the Coast Edmonton Plaza, “The changing face of pediatric TB in Alberta” and “TB 101 for Family Physician”, March 13 and 14, 2008.

72. Global Lung Health Conference, “TB in the Indigenous Peoples of Canada”, Edmonton, AB, March 27 and 28, 2008.

CV: Richard Long

73. Critical Care Grand Rounds, University of Alberta, “Critical Illness due to Tuberculosis”, Edmonton, AB, March 6, 2008.

74. Atlantic Canada MOHs Annual Meeting, “What’s New in the 6th Edition of the Canadian Tuberculosis Standards”, Moncton, New Brunswick, May 8, 2008.

75. The Alphabet Soup Conference, CHR/DOTW Conference. “TB Control on the Front Lines”, June 11, 2008.

76. Medical Grand Rounds, University of Alberta. “The Tuberculosis Program Evaluation and Research Unit: some activities”, December 12, 2008

77. 7th Tuberculosis Conference – Stop TB Yes We Can, FNIH School Screening Program Review. Edmonton, Alberta, March 25-26, 2010

78. 7th Tuberculosis Conference – Stop TB Yes We Can. Determinants of TB Transmission. Edmonton, Alberta, March 25-26, 2010

79. 7th Tuberculosis Conference – Stop TB Yes We Can. TB Prevention and Control: A Public Health, Community, University Collaboration. Edmonton, Alberta, March 25-26, 2010

80. First Nations and Inuit Health Branch – 2nd Biennial First Nations, Inuit and Metis Health

Research Meeting. Disparity in the Incidence Rates of Tuberculosis, in Particular Infectious Tuberculosis between Aboriginal and non-Aboriginal Groups on the Prairies; Ottawa, Ontario, May 13-14, 2010

81. First Nations and Inuit health Branch. Tuberculosis National Strategy Working Group. “Determinants of TB Transmission: National Strategy Recommendations”, Calgary, Alberta, May 21, 2010

82. CHICA – CANADA. “Community Infection Prevention and Control Issues: Lessons from the Determinants of Transmission (DTT) and other Projects on the Prairies. Vancouver, British Columbia, May 29- June 3, 2010

83. First Nations and Inuit Health Branch. “Discussion on the Renewal of the Tuberculosis

Strategy: “The Epidemiology of TB on the Prairies”. Ottawa, Ontario, September 16 and 17, 2010

84. First Nations and Inuit Health, Alberta Region School Screening Review Teleconference’. “The Tuberculosis Skin Test is unreliable in low risk Bacille Calmette-Guérin (BCG) – vaccinated School Children”. Canada Place, Edmonton, Alberta, September 20, 2010

85. TB: What we know and what lies below. The Ontario Lung Association. “HIV Screening in TB Care: HIV Opt-out the Alberta Experience.” Toronto, Ontario, November 16, 2010.

86. Southern First Nations Tuberculosis Conference. West Region Tribunal Council Health

Department. “TB Past, Present and Future”. Brandon, Manitoba, November 17, 2010.

87. Continuous Professional Learning’s URBAN Physicians Learning Program. “CSI Alberta”. Telus Centre, University of Alberta, January 26, 2011.

88. World TB Day, “On the move against tuberculosis: educate to accelerate action”. “TB in children; transmission, and the withdrawal of BCG vaccine”. University of Manitoba, Winnipeg, Manitoba, March 24, 2011.

89. “On the move against tuberculosis: educate to accelerate action”. “Determinants of TB Transmission on the prairies” .World TB Day, University of Manitoba, Winnipeg, Manitoba, March 24, 2011.

90. Manitoba Respiratory Health Professional Group, Manitoba Lung Association. “TB 101”. Winnipeg, Manitoba, March 24, 2011

CV: Richard Long

91. “A Breathe of Fresh Air”. Canadian Respiratory Conference. “Update on Tuberculosis (TB) Diagnostics. Niagara Falls, Ontario, April 29, 2011.

92. Provincial Health Office, Alberta Health and Wellness. “TB Program Update – A Year Later” Edmonton, Alberta. June 2, 2011

93. First Nations and Inuit Health Branch, Alberta Region, Health Canada. “DTT and Satellite projects” Edmonton, Alberta. June 16, 2011

94. Provincial Primary Care Tuberculosis Education Day. “Tuberculosis and Primary Care in Canada” Saskatoon, Saskatchewan, October 28th, 2011

95. Rocky Mountain/American College of Physicians Internal Medicine Conference. (i) “New tests for the diagnosis of latent and active TB”, (ii) (AM Edwards Lecture) “The early diagnosis of pulmonary tuberculosis” Banff, Alberta. November 24-27, 2011

96. Medical Grand Rounds, University of Alberta. “Tuberculosis in the Aboriginal Peoples of Alberta and the other Prairie Provinces: Lessons from the DTT project”, Edmonton, AB. December 9, 2011

97. U of A "Public Health & Preventive Medicine" (PHPM) Academic Half-Day (AHD).

“Tuberculosis and Public Health”, Edmonton, AB. February 10, 2012

98. FNIHB Face-to-Face Meeting. “Tuberculosis Prevention and Control in First Nations Communities on the Prairies; Insights from the “Determinants of TB Transmission” and related projects/New Technologies” Ottawa, ON. February 29, 2012

99. FNIHB Face-to-Face Meeting. “The Determinants of Tuberculosis Transmission in the Canadian-Born Population of the Prairie Provinces: Overview and Status Update” Ottawa, ON. March 1, 2012

100. CIHR Best Brains Exchange 2012. The “Determinants of Tuberculosis Transmission” (DTT) Project: Implications for Aboriginal Health and Policy” Ottawa, ON. March 2, 2012

101. Keewatin Tribal Council, Tuberculosis Conference. “The Determinants of Tuberculosis Transmission (DTT) Project and Related Projects in the Prairie Provinces”, Thompson, MB. March 5-6, 2012

102. 8TH Tuberculosis Symposium 2012. “The Determinants of TB Transmission (DTT) and Related Projects in the Prairie Provinces” Edmonton, AB. March 22-23, 2012

103. 8th Tuberculosis Symposium 2012. “The early diagnosis of pulmonary tuberculosis” Edmonton, AB. March 22-23, 2012

104. Inter provincial TB Working Group Meeting. “The ‘DTT Project’ and Health Canada’s Strategy Against Tuberculosis for First Nations On-Reserve” Winnipeg, MB. May 24, 2012

105. Canadian Public Health Association CPHA 2012. “The importance of TB and housing and its impact on TB transmission, reactivation, severity and prevention” Edmonton, AB. June 11, 2012

106. Grand Challenges Canada: Workshop on Materials and Instrument Development for Novel

Disease Diagnostic Devices. “MDR-TB in Alberta: Early Detection” Edmonton, AB. August 28-29, 2012.

107. Prairie-wide Provincial Network Committee of the “Determinants of TB Transmission”

project and the “Interprovincial TB Working Group”. “Outbreaks, High Incidence Communities and the Social Determinants of Health: Lessons from the ‘DTT’ Project”. Art Gallery of Alberta, Edmonton, AB. September 20, 2012.

108. Prairie-wide Provincial Network Committee of the “Determinants of TB Transmission”

project and the “Interprovincial TB Working Group”. “DTT Summary; status of data

CV: Richard Long

collection/processing: next steps”. Art Gallery of Alberta, Edmonton, AB. September 21, 2012.

109. First Nations and Inuit Health Branch’ Developing Approaches to Monitoring and

Evaluation for Health Canada’s Strategy Against Tuberculosis for First Nations on Reserve. “Emerging Issues in TB Prevention and Care”. Ottawa, ON. October 30-31, 2012.

110. First Nations and Inuit Health Branch’ Developing Approaches to Monitoring and

Evaluation for Health Canada’s Strategy Against Tuberculosis for First Nations on Reserve. “Outbreaks, high incidence communities and the social determinants of health: A brief update from the DTT Project”. Ottawa, ON. October 30-31, 2012.

111. TB: Making a difference. Ontario Lung Association. “Early Diagnosis of Pulmonary TB and Leading New Treatment Recommendations in the 7th Edition of the Canadian TB Standards”. Toronto, ON. November 19-20th, 2012

112. Pulmonary Research Group. University of Alberta. “Increase in multi-drug resistant tuberculosis in Alberta among foreign-born persons: implications for tuberculosis management. Edmonton, AB. January 9, 2013

113. Tuberculosis in Nunavut conference. “Leading New Treatment Recommendations in the 7th Edition of the Canadian TB Standards”. Iqaluit, NU. January 29-31, 2013.

114. Tuberculosis in Nunavut conference. “Teaching Tuberculosis: A resource-guide for Aboriginal and non-Aboriginal youth”. Iqaluit, NU. January 29-31, 2013.

115. Manitoba First Nations Tuberculosis Strategic Planning Meeting. “An update on the DTT project: Some considerations specific to Manitoba”. Winnipeg, MB. February 5-7, 2013.

116. University of Alberta Students’ International Health Association. “Tuberculosis and How it Relates to the Social Determinants of Health.” Edmonton, AB. March 6, 2013.

117. AB NEAHR and BC Kloshe Tillicum and AHRNET Symposium to Explore the Role of

Indigenous Knowledge in Aboriginal Peoples’ Health and Research. “Addressing TB Prevention and care in High Incidence First Nations and Métis Communities on the Prairies”. Vancouver, BC. March 12-13, 2013.

118. Interprovincial TB Working Group meeting. “Highlights and Major changes: the 7th Edition

of the Canadian TB Standards. Videoconference: Edmonton, Saskatoon and Winnipeg, May 9, 2013

119. Advisory Committee, Saskatchewan TB Control Program. “From DTT to FNIHB Strategy to Pathways to Health Equity of Aboriginal Peoples on the Prairies”. Saskatoon, SK, November 6, 2013.

120. Pulmonary Research Group Seminar. “A 10-year Population-based Study of ‘Opt-Out’ HIV Testing of Tuberculosis Patients in Alberta, Canada: National Implications”. Edmonton, AB, November 27, 2013

121. 9th Alberta TB Symposium. “Determinants of Tuberculosis Transmission in the Canadian-born Population of the Prairie Provinces (The “DTT Project”): An Update”. Edmonton, AB, March 20, 2014.

122. 9th Alberta TB Symposium. “MDR-TB: Scope and Trends in Alberta & Canada”. Edmonton, AB, March 20, 2014.

123. Atlantic Medical Officers of Health Meeting. The 7th Edition of the Canadian Tuberculosis Standards. Charlottetown, PEI, May 8, 2014 (by Webinar)

124. CTS Scientific Program, American College of Chest Physicians Annual CHEST Conference. “Tuberculosis, Canada and you”. Austin, TX, October 27th, 2014.

CV: Richard Long

125. Pathways to Health Equity for Aboriginal Peoples. La Loche and Clearwater River, La Loche Health Centre, Saskatchewan, June 10, 2014.

126. Pathways to Health Equity for Aboriginal Peoples. Fort McMurray Community Health Services, Fort McMurray, AB, July 9, 2014.

127. Pathways to Health Equity for Aboriginal Peoples. Chipewyan Prairie First Nation Health Centre, Janvier/Chard, AB, July 9, 2014.

128. Pathways to Health Equity for Aboriginal Peoples. Athabasca Tribal Council, Fort McMurray, AB, September 17, 2014.

129. Pathways to Health Equity for Aboriginal Peoples. La Loche Health Centre, La Loche and Clearwater River, Saskatchewan, September 23, 2014.

130. Tuberculosis Mortality in Alberta and Canada co-presented to the Pulmonary Research Seminar by Dr.’s Anu Parhar and Richard Long, January 14, 2015.

131. Tuberculosis Elimination in Canada. TB VETS 70th Anniversary Symposium. IUATLD NAR Meeting, Vancouver, Feb 25, 2015.

132. Tried and True Interventions in Tuberculosis Control. Pathways to Health Equity for Aboriginal Peoples symposium, Edmonton, AB, May 7-8, 2015.

133. Tuberculosis Elimination in Canada. Stop TB Canada Webinar, October 20, 2015.

134. The Effect of Isoniazid Resistance on the Generation of Secondary Cases of Tuberculosis:

A Case-Control Study. Pulmonary Research Seminar, Edmonton. December 2, 2015.

135. Tuberculosis Elimination in Canada: Can we get there? IUATLD NAR 20th Annual TB Conference 2016 Denver, CO, February 24-27, 2016.

136. Making a Timely Diagnosis of Pulmonary Tuberculosis. Medical Grand Rounds, Stanton Territorial Hospital, Yellowknife, NWT, March 3, 2016.

137. Chest Radiographic Patterns and the Transmission of Tuberculosis: Implications for

Automated Systems. Pulmonary Research Seminar, co-presented with Angela Lau, March 30, 2016.

138. Tuberculosis Elimination in Low Burden Countries: The Canadian Context. Canadian TB Elimination Network Symposium. Toronto, Canada. June 12-13, 2016.

139. Do “Virtual” and “Outpatient” public health tuberculosis clinics perform equally well? A

program-wide evaluation in Alberta, Canada. TB Journal Club. Winnipeg Regional Health Authority, Winnipeg, Manitoba. September 23, 2016.

140. A Clinical Heuristic for Making a Timely Diagnosis of Pulmonary Tuberculosis. TB Journal Club. Winnipeg Regional Health Authority, Winnipeg, Manitoba. September 23, 2016.

141. Do “Virtual” and “Outpatient” public health tuberculosis clinics perform equally well? A

program-wide evaluation in Alberta, Canada. Pulmonary Research Seminar. Co-presented with Courtney Heffernan PhD(c), University of Alberta Hospital, Edmonton, Alberta. September 28, 2016.

142. Tuberculosis Elimination in Canada (plenary). TB Elimination: Back to Basics. Ontario Lung

CV: Richard Long

Association. Toronto, Ontario. November 15-16, 2016.

143. Canadian TB Elimination Network (CTBEN) Symposium (Chair, Introductory and concluding remarks). Vancouver, BC. February 22, 2017.

144. Implementing the “Patients’ Charter for Tuberculosis Care” and the elimination of

tuberculosis in high-incidence communities. First Nations Health Authority 2017. Communicable Disease Workshop, Vancouver, BC. February 22, 2017.

145. Virtual Clinic Models for Managing Remote Care. IUATLD North American Region, END TB: 2017 Conference, Vancouver, BC. February 22-25, 2017.

XV ACTIVE GRANTS OR TRUSTS

1. CIHR (Awarded in 2009)

“Randomized controlled trial of 9 months of INH vs 4 months of rifampin

for treatment of latent TB infection” Co-Investigator (Principal Investigator: Dick Menzies) $4,977,928 (over 7 years)


“A randomized trial to compare effectiveness of 4 months rifampin (4RIF) with 9 months

isoniazid (9 INH) in the prevention of active TB in children, the P4V9 trial” Co-Investigator (Principal Investigator: Dick Menzies) $1,242,325 (over 4 years)


“Evaluation of Potential Biomarkers of Successful Treatment of Latent Tuberculosis” Co- Investigator (Principal Investigator: Dick Menzies) $559,608

(over 3 years) 4. CIHR (Awarded in 2014)

“Modelling the Impact of Intervention for Tuberculosis Control in Inuit Communities” Co-investigator (Principal Investigator: Kevin Schwartzman) $141,692 (over 1.5 years)

5. CIHR (Awarded 2014)

Clearing the Pathways to Health Equity. Applied Public Health Research Chair in

Indigenous Health Information and Knowledge Systems Co-investigator (Principal Investigator: Janet Smylie) $693,500 (over 5 years)

6. PHAC (Awarded 2014)

Clearing the Pathways to Health Equity. Applied Public Health Research Chair in

Indigenous Health Information and Knowledge Systems Collaborator (Principal Investigator: Janet Smylie) $231,000 (over 5 years)


CV: Richard Long

Tracking the two greatest obstacles to tuberculosis elimination: treatment of latent

infection and drug-resistant disease. Co-investigator (Principal Investigator: Dick Menzies) $7,899,731

(over 7 years) 8. University of Alberta Hospital Foundation (Awarded 2015)

A Clinical Heuristic to Determine the Likelihood of Typical Adult-Type Pulmonary

Tuberculosis. Principal Investigator $35,000

(over 1 year) 9. CIHR (Awarded 2017)

Implementing the “Patients’ Charter of Tuberculosis Care” in High-Incidence Indigenous

Communities and Across Jurisdictional Borders. Principal Investigator $675,000

(over 3 years) 10. (SHRF) Saskatchewan Health Research Foundation (Awarded 2017)

Implementing the “Patients’ Charter of Tuberculosis Care” in High-Incidence Indigenous

Communities and Across Jurisdictional Borders. Principal Investigator $150,000

(over 3 years)

XVI Past National Grants (Principal Investigator):

1. CIHR, First Nations and Inuit Health Branch, Health Canada, and Aboriginal Capacity and

Developmental Research Environments (Awarded in 2006)

“The Determinants of Tuberculosis Transmission in the Canadian-born

Population of the Prairie Provinces”. $722,247.00 Principal Investigator (over 7 years)

2. First Nations and Inuit Health Branch, Communicable Disease Control Division, Health Canada;

First-Nations and Inuit Health Branch, Alberta Region; Department of Medicine Research Overhead Account; Aboriginal Capacity and Developmental Research Environments (2007)

“The Determinants of Tuberculosis Transmission in the Canadian-born

Population of the Prairie Provinces”. Principal Investigator $812,026.00 (over 7 years)

3. CIHR, Planning and Dissemination Grant (Awarded in 2011); Prairie-wide Provincial Network

Committee Meeting. “The Determinants of Tuberculosis Transmission in the Canadian-born

Population of the Prairie Provinces” Principal Investigator $25,000

(over 1 years)

4. Public Health Agency of Canada, Lung Health Program Phase I and II (Awarded in 2011)

“Tuberculosis Education in Canadian Aboriginal and Non-Aboriginal Youth: An Historical,

Socio-Cultural and Public Health Promotional Curriculum” Principal Investigator (Co-Principal Investigator: Malcolm King) $400,000 (over 2 years)


CV: Richard Long

“Informing the Strategy Against Tuberculosis for First Nations On-reserve: Evidence from

the DTT Project” Principal Investigator $200,000 (over 2years)


“Reducing the Burden of Tuberculosis in the Foreign-born through an Expanded Program

of Post-landing Immigration Medical Surveillance: A Nationwide Study in Canada, 2003-

2010” Principal Investigator $247,926 (over 3 years)


Implementing the “Patients Charter for Tuberculosis Care” in high incidence indigenous

communities and across jurisdictional borders. Pathways to Heath Equity for Aboriginal

Peoples – Implementation Research Team – Component 1 Program. Principal Investigator $100,000 (over 18 months)


Implementing the “Patients Charter of Tuberculosis Care” in High Incidence Indigenous

Communities and across Jurisdictional Borders. Developmental Grant Principal Investigator $3422.50

(over 6 mo)

XVII MAJOR CONTRACTS. Proceeds Payable to the TB Program Evaluation and Research Unit

1. Editor-in-chief, 5th edition Canadian Tuberculosis Standards, 2000 $7,500

2. External review: Hamilton-Wentworth MDR-TB Outbreak, 2000-2001. May 7, 2001 $5,000

3. External review: Tuberculosis Control Program of Manitoba, (Sanatorium Board of Manitoba). February 12-14, 2003 $7,500

4. Program Evaluation: Tuberculosis Control and Management Project for $30,000

Continuing Care. Alberta Health and Wellness. 2002-2003

5. Re-write: Tuberculosis Guidelines for Federal Correctional Centres. $60,000 Correctional Services Canada/Health Canada. 2002-2003

6. External review: Tuberculosis Control Program of Saskatchewan, 2003-2004 $25,000

7. Northwest Territories Physicians and Nurses: Advanced Training course in Tuberculosis. 2006 $1,000

8. First Editor, 6th Edition, Canadian Tuberculosis Standards, 2007 $7,500

9. Tuberculosis Consultant: First Nations and Inuit Health, Prairie Regions. 2010 $65,000 Jan 2008 – Sept 2010

10. Tuberculosis Consultant: First Nations and Inuit Health Branch, Headquarters. $194,000 October 2009 – Sept 2014

11. TB Report and Performance Indicators: Alberta Health and Wellness. 2011 $25,000

CV: Richard Long

12. TB Awareness Activities in the Foreign-Born, Public Health Agency of Canada. 2012 $20,000

13. Medical-Legal Opinion. 2014 $30,000

14. Tuberculosis Consultant: Northwest Territories. 2015-2017 $71,000

XVIII CURRENT GRADUATE STUDENTS AND RESIDENTS IN TRAINING

Doctoral Students

Betsy Varughese PhD Interdisciplinary (co-supervisor with Michael Li)

CIHR, PhD award Frederick Banting and Charles Best Canada Graduate Scholarship Alberta Innovates Health Solutions

Stipend: $30,000/yr x 3 years Allowance: $5,000/yr x 3 years Stipend: $30,000/yr x 2 years Allowance: $2,000/yr x 2 years

Courtney Heffernan PhD Medicine (supervisor)

Network Environments for Aboriginal Health Research CIHR Applied Public Health Chair

$14,000 (yr. 1) $35,000

Leyla Asadi, MD PhD Medicine (co-supervisor with Mercedes Beccera, Harvard University

Alberta Innovates Health Solutions Clinical Fellowship

Stipend: $70,000/yr x 3 years

Master Students

Degree Funding Agency Amount Awarded

Kimberly Quach MSc (co-supervisor with Duncan Saunders)

Western Regional Training Centre for Health Services Research

$17, 800

XIX PAST GRADUATE STUDENTS, PROJECT TRAINEES AND THEIR PUBLICATIONS (see

publication list XX)

Graduate Students: Deanne Langlois-Klassen ............................ PhD .......................................................... 94, 97, 98, 100, 101 Deanne Langlois-Klassen ............................ Post-Doctoral Fellow ......................................... 103, 109, 111 Jessica Moffatt ............................................. PhD ............................................................................ 106, 114 Zhiwei Gao ................................................... Post-Doctoral Fellow ................................. 115, 116, 117, 118 David Yip ...................................................... MPH (Bloomberg School Public Health) .............................. 69 Anne Aspler .................................................. MPH Student (LSTMH) .................................................. 84, 86

CV: Richard Long

Lisa Eisenbeis .............................................. MSc…………………………………………………………….126 Smit Patel ..................................................... MSc………………………………………………………..pending Angela Lau ................................................... MSc…………………………………………95, 97,108,125, 127 Jennifer Bown ............................................... MPH Student (LSTMH) …………………………………pending Natalia Fedkina ………………………………..MPH (Field Practicum) ………………………..(Internal Report)

Project-related Trainees: (Projects completed) Charles Penner ............................................ Respiratory Fellow ......................................................... 21, 22 Shurgeel Choudhri ....................................... ID Fellow ........................................................................ 23, 26 Ahmed Bahammam ..................................... Respiratory Fellow ......................................................... 34, 35 Ahmed Hersi ................................................. Respiratory Fellow ............................................................... 38 Sandy Jacobs ............................................... FNIHB Nurse ................................................................. 68, 95 Angela Lau……………………………………...AIHS and NSERC Summer Student & Medical Resident…………………….…95, 97, 108, 125, 127 Doris Sturtevant ............................................ Community Medicine Resident ............................................ 78 June Hwang ................................................. Pathology Resident .............................................................. 85 Mike Jensen .................................................. AIHS Summer Student ........................................................ 97 Jesse Minion ................................................ Medical Microbiology ......................................................... 105 Vivek Dhawan .............................................. Respiratory Fellow ............................................................. 111 Anu Parhar ……………… .............................. Respiratory Fellow ..................................................... 117, 118 David Long ……………………………………. AIHS Summer Student ……………………………………...124 Hong Zhou ..................................................... Medical Microbiology ......................................................... 124 Jalal Moolji ………………………………...….. General Internal Medicine ……………………………...pending Brenden Kunimoto ………………………….... Undergraduate FoMD, UofA……………………………pending Gauri Shah ……………………………………..Pediatric ID fellow………………………………………..pending

XX PUBLICATIONS

CV: Richard Long

Journal Publications: (* First author was a Fellow/Resident or other trainee/colleague under my

supervision or co-supervision)

1. Sandoval J, Long R, Skoog C, Wood LDH, Oppenheimer L. Independent influence of blood flow

rate and mixed venous PO2 on shunt fraction. J Appl Physiol 1983;55:1128-1133. 2. Sznajder I, Zucker A, Wood LDH, Long R. The effects of plasmapheresis and hemofiltration on

canine acid aspiration pulmonary edema. Am Rev Respir Dis 1986;134:222-228. 3. Mayers I, Long R, Breen P, Wood LDH. Artificial ventilation of a canine model of bronchopleural

fistula. Anesthesiology 1986;64:739-746.

4. Long R, Scalcini M. Hôpital Albert Schweitzer and the Republic of Haiti. J Community Health 1986;11:77-91.

5. Breen PH, Becker LJ, Ruygrok P, Mayers I, Long R, Leff A, Wood LDH. Canine

bronchoconstriction, gas trapping and hypoxia with methacholine. J Appl Physiol 1987;63:262-269.

6. Long R, Kassum D, Donen N, De Pape A, Taylor J, Warrian K. Cardiac tamponade complicating

central venous catheterization for total parenteral nutrition: a review. J Crit Care 1987;2:39-44. 7. Long R, Wood LDH, Sznajder I. An in vitro calibration of the thermodilution method of cardiac

output determination. J Extracorpor Technol 1987;19:221-227. 8. Gottlieb SS, Wood LDH, Hansen DE, Long R. The effect of nitroprusside on pulmonary edema,

oxygen exchange and blood flow in hydrochloric acid aspiration. Anesthesiology 1987;75:203-210.

9. Schumacker PT, Long R, Wood LDH. Tissue oxygen extraction during hypovolemia: role of

hemoglobin P50. J Appl Physiol 1987;62:1801-1807. 10. Mayers I, Breen PH, Gottlieb S, Long R, Wood LDH. The effects of indomethacin on edema and

gas exchange in canine acid aspiration. Respir Physiol 1987;69:149-160. 11. Long R, Nelson D, Sznajder I, Wood LDH, Schumacker PT. Systemic oxygen delivery and

consumption during acute lung injury in dogs. J Crit Care 1988;3:249-255. 12. Long R, Breen PH, Mayers I, Wood LDH. Treatment of Canine acid aspiration pneumonitis: fluid

volume reduction vs fluid volume expansion. J Appl Physiol 1988;65:1736-1744. 13. Long R, Filuk R, Balakumar M, Easton PA, Anthonisen NR. Ventilatory response to sustained

hypoxia: effect of methysergide and verapamil. Respir Physiol 1989;75:173-182. 14. Long R, Younes M, Patton N, Hershfield E. Tuberculous Pericarditis: long term outcome in

patients who received medical therapy alone. Am Heart J 1989;117:1133-1139.

15. * Scalcini M, Carre G, Jean-Baptiste M, Hershfield E, Parker S, Wolfe J, Nelz K, Long R.

Antituberculous drug resistance in central Haiti. Am Rev Respir Dis 1990;142:508-511.

CV: Richard Long

16. Long R, Scalcini M, Manfreda J, Carre G, Phillippe E, Hershfield E, Sekla L, Stackiw W. Impact of

human immunodeficiency virus type 1 on pulmonary tuberculosis in rural Haiti. Am Rev Respir

Dis 1991;143:69-73. 17. Long R, Maycher B, Scalcini M, Manfreda J. The chest radiograph in pulmonary tuberculosis

patients seropositive for human immunodeficiency virus type-1. CHEST 1991;99:123-127.

18. * Scalcini M, Occenac R, Manfreda J, Long R. Pulmonary tuberculosis, human immunodeficiency

virus type-1 infection and malnutrition. Bull Int Union Tuberc 1991;66:37-41. 19. Long R, Scalcini M, Jean-Baptiste M, Manfreda J, Hershfield E. The impact of HIV on the

usefulness of sputum smears for the diagnosis of tuberculosis. Am J Public Health 1991;81:1326-1328.

20. Long R, Manfreda J, Mendella L, Parker S, Wolfe J, Hershfield E. Antituberculous drug resistance

in the Province of Manitoba (1980-89). CMAJ 1993;148:1489-1495.

21. * Penner C, Maycher B, Long R. Lung Gangrene: A complication of bacterial pneumonia.

CHEST 1994;105:567-573.

22. * Penner CG, Roberts D, Kunimoto D, Manfreda J, Long R. Tuberculosis as a primary cause of

respiratory failure requiring mechanical ventilation. Am J Respir Crit Care Med 1995;151:867-72.

23. * Choudhri S, Manfreda J, Wolfe J, Parker S, Long R. Clinical Significance of the Isolation of

Nontuberculosis Mycobacteria in a Canadian Tertiary Care Centre. Clin Infect Dis 1995;21:128-133.

24. Long R, O'Connor R, Palayew M, Hershfield E, Manfreda J. Disseminated Tuberculosis With and

Without a Miliary Pattern on Chest Radiograph. Int J Tuberc Lung Dis 1997;1:52-58. 25. Long R, Fanning A, Cowie R, Hoeppner V, FitzGerald M and the Western Canada Tuberculosis

Group. Antituberculous Drug Resistance in Western Canada (1993-94). Can Respir J 1997;4:71-75.

26. * Choudhri S, Hawken M, Gathua S, Minyiri GO, Watkins W, Sahai J, Sitar D, Aoki F, Long R. The

Pharmacokinetics of Antimycobacterial Drugs in Patients with Tuberculosis, AIDS and Diarrhea.

Clin Infect Dis 1997;25:104-11. 27. Long R, Maycher B, Dhar A, Manfreda J, Hershfield E, Anthonisen A. Pulmonary Tuberculosis

Treated with Directly Observed Therapy: Serial Changes in Lung Structure and Function. CHEST 1998;113:933-43.

28. Long R, Maycher B. Check-Valve Pneumatocele Formation Following Fully Treated Tuberculosis.

Can Assoc Radiol J 1998;49:197-99. 29. Sznajder JI, Nahum A, Hansen D, Long GR, Wood LDH. Volume recruitment and oxygenation in

pulmonary edema: A comparison between HFOV and CMV. J Crit Care 1998;13:126-135.

CV: Richard Long

30. * Arvanitakis Z, Long R, Hershfield E, Manfreda J, Kabani A, Kunimoto D, Power C. M.

tuberculosis Molecular Variation in CNS Infection. Evidence of Strain Dependent Neurovirulence.

Neurology 1998;50:1827-32. 31. Long R, Njoo H, Hershfield E. The Epidemiology of Tuberculosis in Canada: Implications for

Diagnosis and Treatment. CMAJ 1999;160:1185-90.

32. Long R, Cowie R. Pulmonary Tuberculosis: Making a Timely Diagnosis. CMAJ 1999;160:1344-48

33. Long R, Guzman R, Greenberg H, Safneck J, Hershfield E. Tuberculous mycotic aneurysm of the

aorta: Review of Published Medical and Surgical Experience. CHEST 1999;115:522-531.

34. * Bahammam A, Choudhri S, Long R. The validity of acid-fast smears of gastric aspirates as an

indicator of pulmonary tuberculosis. Int J Tuberc Lung Dis 1999;3:62-67.

35. * Bahammam A, Choudhri S, Long R. Utility of gastric aspirates in screening for pulmonary

tuberculosis in high risk subjects: The Manitoba Experience. Can J Infect Dis 1999;10:69-73.

36. Long R, Light B, Talbot J. The mycobacteriocidal action of exogenous nitric oxide. Antimicrob

Agents Chemother 1999;43:403-5. 37. Long R, Nobert E, Chomyc S, van Embden J, McNamee C, Rey Duran R, Talbot J, Fanning A.

Transcontinental spread of multidrug-resistant Mycobacterium bovis. Am J Respir Crit Care Med 1999;159:2014-17.

38. * Hersi A, Elwood K, Cowie R, Kunimoto D, Long R. Multidrug-Resistant Tuberculosis in Western

Canada (1989-98). Can Respir J 1999;6:155-60. 39. Long R, Scalcini M. Is treatment of WHO “category 1” tuberculosis with “2 HRZE/6 HE” a

defensible practice? Int J Tuberc Lung Dis 1999;3:747-8.

40. * Maycher B, O'Connor R, Long R. CT Abnormalities in M. Avium Complex Lung Disease Include

the Mosaic Pattern of Reduced Lung Attenuation. Can Assoc Radiol J 2000;51:93-102.

41. * Farzad E, Holton D, Long R, FitzGerald M, Njoo H, Laszlo A, Fanning A, Hershfield E, Hoeppner

V, Allen E. Drug Resistance Study of Mycobacterium tuberculosis in Canada. Can J Public

Health 2000; 91:366-70. 42. Long R, Chomyc S, Der E, Sitar D S. “Pseudo” treatment failure of pulmonary tuberculosis in

association with a tuberculoma. Can Respir J 2000;7:79-83.

43. Long R. Drug-resistant tuberculosis. CMAJ 2000;163:425-8. 44. Long R, Scalcini M. More on the question of optimal chemotherapy in the presence of isoniazid

resistance. Int J Tuberc Lung Dis 2000;4:890-4.

45. Long R. Tuberculosis, the CLA/CTS and the new millennium (editorial) Can Respir J 2000;7:24-5.

CV: Richard Long

46. Long R. Introducing the 5th edition of the Canadian Tuberculosis Standards (editorial) Can

Respir J 2000;7:449-501. 47. Heywood N, Kawa B, Long R, Njoo H, Panaro L, Wobeser W, and the Canadian Tuberculosis

Committee. Guidelines for the investigation and follow-up of individuals who were placed under

surveillance for tuberculosis after arrival in Canada. CCDR 2001;27(No.19):157-65 48. Long R, Fanning A, McNamee C, Barrie J, Puttagunta L. Medical versus surgical treatment of a

primary tuberculous pleural peel. Can Respir J 2001;8:449-53. 49. Long R, Chui L, Kakulphimp J, Zielinski M, Talbot J, Kunimoto D. Post sanatorium pattern of

antituberculous drug resistance in the Canadian-born population of western Canada: Effect of

outpatient care and immigration. Am J Epidemiol 2001; 153: 903-11.

50. Long R, Smear-negative pulmonary tuberculosis in industrialized countries (editorial). CHEST 2001;120:330-4.

51. Long R, Zielinski M, Kunimoto D, Manfreda J. The emergency department is a determinant point of

contact of tuberculosis patients prior to diagnosis. Int J Tuberc Lung Dis 2002;6:332-9. 52. Long R, Sutherland K, Kunimoto D, Cowie R, Manfreda J. The Epidemiology of tuberculosis among

foreign-born persons in Alberta, Canada, 1989-1998: Identification of high risk groups. Int J

Tuberc Lung Dis 2002;6:615-21. 53. Long R. Tuberculosis Control in Alberta: a federal, provincial and regional public health

partnership. Can J Public Health 2002;93:264-66. 54. Long R, Houston S, Hershfield E for the Canadian Tuberculosis Committee. Recommendations

for the screening and prevention of tuberculosis (TB) in human immunodeficiency virus (HIV) patients and the screening for human immunodeficiency virus in tuberculosis patients and their

contacts. CCDR 2002;28:1-6. 55. Long R, Houston S, Hershfield E for the Canadian Tuberculosis Committee. Recommendations

for the screening and prevention of tuberculosis (TB) in human immunodeficiency virus (HIV) patients and the screening for human immunodeficiency virus in tuberculosis patients and their

contacts. CMAJ 2003;169:789-91. 56. Long R, Gardam M. Tumour necrosis factor-α inhibitors and the reactivation of latent tuberculosis

infection. CMAJ 2003:168:1153-5. 57. Long R, Bochar K, Chomyc S, Talbot J, Barrie J, Kunimoto D, Tilley P. Relative versus absolute

non-contagiousness of respiratory tuberculosis on treatment. Infect Control Hosp Epidemiol 2003;24:831-38.

58. Gardam M, Keystone EC, Menzies R, Skamene E, Long R, Vinh D. Anti-TNF agents and

tuberculosis: mechanisms of action and clinical management. Lancet - Infect Dis 2003;3:148-155.

59. Long R. New biologic therapies and the risk of tuberculosis in the elderly. Geriatrics and Aging 2003;6:29-34.

CV: Richard Long

60. Heywood N, Kawa B, Long R, Njoo H, Panaro L, Wobeser W, on behalf of the Immigration Subcommittee of the Canadian Tuberculosis Committee. Guidelines for the investigation and follow-up of individuals who were placed under surveillance for tuberculosis after arrival in Canada:

A summary. CMAJ 2003;168:1563-65. 61. Long R, Whittaker D, Russell K, Kunimoto D, Reid R, Fanning A, Nobert E, Melenka L, Yacoub W,

Bhargava R. Pediatric tuberculosis in Alberta First Nations (1991-2000). Outbreaks and the

protective effect of bacille Calmette-Guérin (BCG) vaccine. Can J Public Health 2004;95:249-255.

62. Kunimoto D, Sutherland K, Manfreda J, Wooldrage K, Fanning A, Chui L, Long R. Transmission

characteristics of tuberculosis in the foreign-born and Canadian-born population of Alberta,

Canada. Int J Tuberc Lung Dis 2004;8:1213-20.

63. Long R. Tuberculosis and malnutrition (editorial). Int J Tuberc Lung Dis 2004;8:276-77. 64. Long R, Jones D, Talbot J, Mayers I, Barrie J, Hoskinson M, Light B. Inhaled nitric oxide treatment

of patients with pulmonary tuberculosis evidenced by positive sputum smears. Antimicrob Agents

Chemother 2005;49:1209-12. 65. Long R, Wong E, Barrie J. Bronchial anthracofibrosis and tuberculosis: CT features before and

after treatment. Am J Roentgenol 2005; 184(3 Suppl):S33-6. 66. Kunimoto D, Long R. Tuberculosis – still overlooked as a cause of community acquired

pneumonia. How not to miss it. In Marrie T, ed. Community acquired pneumonia: new facets of

an old disease. Respir Care Clin 2005;11:25-34. 67. Long R. Physician experience, public health and the management of tuberculosis. (Commentary)

CMAJ. 2006; 175:759-60.

68. * Jacobs S, Warman A, Roehrig N, Yacoub W, Wijayasinghe C, Richardson R, Benjamin E,

Chong H, Manfreda J, Long R. Mycobacterium tuberculosis infection and disease in First Nation preschool children in Alberta: implications for BCG (bacille Calmette-Guérin) vaccine withdrawal.

Can J Public Health. 2007; 98: 116-20

69. * Yip D, Bhargava R, Yao Y, Sutherland K, Manfreda J, Long R. Pediatric tuberculosis in Alberta

(1990-2004): Epidemiology and case characteristics. Can J Public Health, 2007; 98:276-80. 70. Gardam M, Kunimoto D, Long R, Menzies D, Pai M. The Canadian Tuberculosis Advisory

Committee Statement on the use of Interferon Gamma Release Assays (IGRA). CCDR, 1 November 2007; 33:ACS 10

71. Long R, Boffa J. Why internationally adopted children should be screened for tuberculosis.

(Commentary) CMAJ 2007; 177:172-3 72. Long R, Ellis E. Introduction to the 6th Edition of the Canadian Tuberculosis Standards (Editorial)

Can Respir J and Can J Inf Dis Med Microbiol, 2007;14:327-328 and 2007;18:283-284 73. Long R. The Canadian Lung Association/Canadian Thoracic Society and Tuberculosis Prevention

and Control. Can Respir J 2007;14:427-431

CV: Richard Long

74. Long R, Barrie J, Stewart K, Peloquin C. Treatment of tuberculous empyema with simultaneous

oral and intrapleural antituberculosis drugs. Can Respir J. 2008; 15:241-43

75. * Lee MC, Takaya S, Long R, Joffe M. Respiratory fit testing: Does it ensure the protection of

healthcare workers against respirable particles carrying pathogens? Infect Control Hosp

Epidemiol 2008; 12:1449-1156 76. Menzies D, Long R, Trajman A, Dion M Yang J, Al Jahdali H, Memish Z, Khan K Gardam M,

Hoeppner V, Schwartzman K. Adverse events with 4 months rifampin or 9 months isoniazid as

therapy for latent TB infection:results of a randomized trial. Ann Int Med 2008; 149:689-697 77. Pai M, Gardam M, Haldane, Kitai I, Kunimoto D, Long R, Menzies D, Morshed M, Ward H,

Wobeser W. Updated recommendations on interferon gamma release assays for latent

tuberculosis infection. CCDR 2008; 34:AC5-6

78. * Sturtevant D, Preiksaitis J, Singh A, Houston S, Gill J, Predy G, Fisher D, Senthilselvan A,

Manfreda J, Boffa J, Long R. The feasibility of using an ‘opt-out’ approach to achieve HIV testing

of tuberculosis patients in Alberta. Can J Public Health 2009; 100:116-20 79. Long R, Chong H, Hoeppner V, Shanmuganathan H, Kowalewska-Grochowska K, Shandro C,

Manfreda J, Senthilselvan A, Elzainy A, Marrie T. Empiric treatment of community acquired

pneumonia and the development of fluoroquinolone-resistant tuberculosis. Clin Inf Dis 2009; 48: 1354-1360

80. Slupsky CM, Rankin KN, Fu H, Chang D, Rowe BH, Charles PGP, McGeer A, Low D, Long R,

Kunimoto D, Sawyer MB, Fedorak RN, Admko DJ, Saude EJ, Shah SL, Marrie TJ. Pneumococcal

pneumonia: Potential for etiologic diagnosis through a urinary metabolic profile. J Proteome

Res 2009; 8 (12); pp 5550–5558. 81. Kunimoto D, Der, E, Beckon A, Cabrita L, Egedahl M, Alexander M, Beatch A, Williams G, Tyrrell

G, Ahmed R, Brown N, Long R. Use of the Quantiferon®-TB Gold test to confirm latent TB

infection in a Canadian tuberculosis clinic. Int J Tuberc Lung Dis 2009; 13: 726-730 82. Xu T, Mandal M, Long R, Basu A. Gradient vector flow based active shape model for lung field

segmentation in chest radiographs. 31st annual International IEEE EMBS Conference. Paper No. 789

83. Long R, Beatch A, Lee MC, Cheung-Lee M, Wasel N. Lupus Vulgaris Occurring in a Locus Minoris

Resistentiae. J Cutaneous Med and Surgery 2009; 13(6):313-316

84. * Aspler A, Chong H, Kunimoto D,Chui L, Boffa J, Long R. Sustained intra- and inter-jurisdictional

transmission of tuberculosis within a mobile, multi-ethnic social network: Lessons for tuberculosis

elimination Can J Public Health 2010; 101: 205-209

85. * Hwang J, Puttagunta L, Green F, Shimanovsky A, Barrie J, Long R. Bronchical anthracofibrosis

and tuberculosis in immigrants to Canada from the Indian subcontinent. Int J Tuberc Lung Dis 2010; 14: 231-237

86. Aspler A, Long R, Trajiman A, Dion M-J, Khan K, Schwartzman K, Menzies D. Health system costs

with 4 months rifampin or 9 months isoniazid as therapy for latent TB infection: results from a

randomized trial. Thorax 2010; 65: 582-587

CV: Richard Long

87. * Webster D, Long R, Shandro C, Pettipas J, Davidson R, Fanning A. Fluoroquinolone resistance

in renal isolates of Mycobacterium tuberculosis. Int J Tuberc Lung Dis 2010; 14: 217-222 88. Long R, Boffa J. High HIV-TB Co-infection Rates in Marginalized Populations: Evidence from

Alberta in Support of Screening TB Patients for HIV (Commentary) Can J Public Health 2010; 101: 202-204

89. Trajman A, Zylberberg D, Dion MG, Al-Otaibi B, Long R, Menzies D. Factors associated with

treatment compliance in a randomized trial of treatment of latent tuberculosis infection. Int J

Tuberc Lung Dis 2010; 14: 551-559 90. Olsen S, Long R, Tyrrell G, Kunimoto D. Induced sputum for the diagnosis of pulmonary

tuberculosis: Is it effective in clinical practice. Can Respir J. 2010 17(4): e81–e84.

91. * Boffa J, King M, McMullin K, Long R. A process for the inclusion of Aboriginal people in health

research: Lessons from the Determinants of TB Transmission Project. Soc Sci Med 2011;72:733-738

92. * Elamy H, Far B, Mandel M, Basu A, Cheng I, Long R. An intelligent CAD system for automated

detection of pulmonary tuberculosis on chest radiograph and CT thorax: a road map. IEEE CCECE

Conference Paper No.1569277319

93. * Elamy H, Far B, Long R. An intelligent multi-agent system for automated detection and diagnosis

of active tuberculosis on chest radiographs SEKE Paper No. 285: 485 – 498

94. * Langlois-Klassen D, Wooldrage K, Manfreda J, Sutherland K, Ellis E, Phypers M, Gushulak B,

Long R. Piecing the puzzle together: foreign-born tuberculosis in an immigrant-receiving country.

Eur Resp J 2011 Oct;38(4):895-902

95. * Jacobs S, Warman A, Richardson R, Yacoub W, Lau A, Whittaker D, Cockburn S, Verma G,

Boffa J, Tyrrell G, Kunimoto D, Manfreda J, Langlois-Klassen D, Long R. The tuberculin skin test is unreliable in school children BCG–vaccinated in infancy and at low risk of tuberculosis infection.

Pediatr Infect Dis J 2011 Sep;30(9):754-8 96. Pepperell C, Granka J, Alexander D, Behr M, Chui L, Gordon J, Guthrie M, Jamieson F, Langlois-

Klassen D, Long R, Nguyen D, Wobeser W, Feldman M. Dispersal of Mycobacterium tuberculosis

via the Canadian fur trade. Proc Natl Acad Sci (USA) 2011 April doi: 10.1073/pnas.1016708108

97. * Jensen M, Lau A, Langlois-Klassen D, Boffa J, Manfreda J, Long R. A population-based study of

TB epidemiology and innovative service delivery in Canada. Int J Tuberc Lung Dis 2012;16:43-49 98. Long R, Hoeppner V, Orr P, Ainslie M, King M, Abonyi S, Mayan M, Kunimoto D, Langlois-Klassen

D, Heffernan C, Lau A, Menzies D. Marked disparity in the epidemiology of tuberculosis among

Aboriginal peoples on the Canadian prairies: the challenges and opportunities. Can Respir J 2013; 20(4): 223-30

99. * McMullin K, Abonyi S, Mayan M, Orr P, Lopez-Hille C, Boffa J, Long R. Evoking ‘Old Keyam’ as a

response to the disproportionate experience of tuberculosis among Aboriginal Peoples of the

Canadian Prairies. J Aboriginal Health 2012;(9): 30-40.

CV: Richard Long

100. * Langlois-Klassen D, Kunimoto D, Saunders D, Chiu L, Boffa J, Menzies D, Long R. A population

based cohort study of Mycobacterium tuberculosis Beijing strains: an emerging public health threat

in an immigrant-receiving country. PLoS ONE 2012 Doi: 10.1371/journal.pone.0038431

101. * Langlois-Klassen D, Senthilselvan A, Kunimoto D, Saunders LD, Menzies D, Long R.

Transmission of Beijing strains of M. tuberculosis in a low incidence setting: time to silence the

alarms? Emerg Infect Dis 2013; 19(5): 701-11.

102. * Xu T, Mandal M, Long R, Cheng I, Basu A. An edge-region force guided active shape approach

for automatic lung field detection in chest radiographs. Comput Med Imaging Graph. 2012; 36(6):452-63

103. Long R, Langlois-Klassen D. Increase in multidrug-resistant tuberculosis (MDR-TB) in Alberta

among foreign-born persons: implications for tuberculosis management. Can J Public Health 2013; 104(1): e22-7

104. * Xu T, Cheng I, Long R, Mandal M. Novel coarse-to-fine dual scale technique for tuberculosis

cavity detection in chest radiographs. Eurasip Journal on Image and Video Processing 2013, 2013:3.

105. * Minion J, Gallant V, Wolfe J, Jamieson F, Long R. Multidrug and extensively drug-resistant

tuberculosis in Canada 1997-2008: demographic and disease characteristics. PLoS ONE (2013), http://dx.plos.org/10.1371/journal.pone.0053466

106. * Moffatt J, Mayan M, Long R. Sanatoriums and the Canadian Colonial legacy: The Untold Story of

Tuberculosis Treatment. Qual Health Res 2013; 23(12): 1591-99

107. * Xu T, Cheng I, Long R, Mandal M. Computer-aided Detection of Acinar Shadows in Chest

Radiographs. ICTACT Journal on Image and Video Processing. 2013; 3(4): 593-604 108. Long R, Lau A, Warman A. Tuberculosis outbreaks in Canada: an historical perspective with

emphasis on community outbreaks in First Nations (North American Indians). Public Health

Action (In preparation)

109. * Varguhese M, Langlois-Klassen D, Long R, Li M. Preventing tuberculosis in the foreign-born

population of Canada: A Mathematical modeling study. Int J Tuberc Lung Dis 2014; 18(4): 405-412

110. Rozmus J, Junker A, Thibodeau ML, Grenier D, Turvey SE, Yacoub W, Embree J, Haddad E,

Langley J, Ramsingh R, Singh V-A, Long R, Schultz KR. Severe Combined Immunodeficiency

(SCID) in Canadian children: A prospective National Surveillance Study. J Clin Immunol 2013. DOI 10.1007/s 10875-013-9952-8

111. * Dhawan V, Bown J, Lau A, Bhargava R, Langlois-Klassen D, Kunimoto D, Chui L, Collin S, Long

R. The changing face of pediatric tuberculosis in high income, low incidence countries: a 25-year

conventional and molecular epidemiologic study. Pediatrics (In preparation)

CV: Richard Long

112. Long R, Niruban J, Heffernan C, Cooper R, Ahmed R, Fisher D, Egedahl ML, Fur R. A 10-year Population-based Study of ‘Opt-Out’ HIV Testing of Tuberculosis Patients in Alberta, Canada:

National Implications. PLoS ONE (2014) 9 (6): e98933 doi:10. 1371/Journal.Pone.0098933

113. * Varughese M, Long R, Li M. A Mathematical model of latent tuberculosis infection in the foreign-

born population of Canada. Mathematical Population Studies. 2017; 24(1): 21-36.

114. * Moffatt J, Long R, Mayan M. Taking care of our own: the multifaceted relationship between on-

reserve housing and tuberculosis occurrence. Pimatisiwin: A Journal of Indigenous and

Aboriginal Community Health 2013; 11(3): 555-64 115. Long R, Heffernan C, Gao Z, Egedahl M, Talbot J. Do “virtual” and “outpatient” public health

tuberculosis clinics perform equally well?: a program-wide evaluation in Alberta, Canada. PLoS

One 2015. 10(12): e0144784.doi:10.1371/journal.pone.0144784 116. Mah A, Kharrat H, Ahmed R, Gao Z, Der E, Hansen E, Long R, Kunimoto D, Cooper R. Serium

drug concentrations of isoniazid and rifampin as a predictor of 2-month sputum culture results in

patients with pulmonary tuberculosis. Int J Tuberc Lung Dis 2015; 19: 210-215

117. * Parhar A, Gao Z, Heffernan C, Ahmed R, Egedahl M, Long R. (2015) Is early tuberculosis death

associated with increased tuberculosis transmission? PLoS ONE 10(1): e0117036 doi: 10.1371/journal.pone. 0117036

118. * Gao Z, Parhar A, Gallant V, Ahmed R, Heffernan C, Egedahl M, Manfreda J, Long, R. A

population-based study of tuberculosis case-fatality in Canada: Do Aboriginal peoples fare less

well? Int J Tuberc Lung Dis 2015; 19: 772-778

119. * Komarnisky S, Hackett P, Heffernan C, Abonyi S, Long, R. “Years Ago”: reconciliation and First

Nations narratives of tuberculosis in the Canadian Prairie Provinces. Crit Public Health Available at: http://dx.doi.org/10.1080/09581596.2015.1067672

120. Long, R, Barrie J, Peloquin C. Therapeutic Drug Monitoring and the Conservative Management of

Chronic Tuberculous Empyema. Case Report and Review of the Literature BMC Infect Dis (2015) 15:327. DOI 10.1186/s 12879-015-1093-7

121. Abonyi S, Mayan M, McMullin K, Lopez-Hille C, Boffa J, Heffernan C, Orr P, Hoeppner V, King M,

Long R. “Finally when I started falling down”: Indigenous TB patient experiences of health and

illness on the Canadian Prairies. Int J Indigenous Health (In Press).

122. Long R, Ellis E. TB elimination in Canada Truce or Victory? CMAJ 2015. DOI: 10.1503/cmaj.150317 or 2015; 187(16):1191-92.

123. Long R. Making a Timely Diagnosis of Pulmonary Tuberculosis. Can Respir J 2015; 22(6):317-321.

124. * Zhou H, Long D, Gao Z, Christianson S, Sharma M, Wolfe J, Heffernan C, Long R. The Effect of

Isoniazid Resistance on the Generation of Secondary Cases of Tuberculosis: a case-control study.

JID (In preparation)

CV: Richard Long

125. * Lau A, Barrie J, Winter C, Elamy R-H, Tyrrell G, Long R. (2016) Chest radiograph patterns and

the transmission of tuberculosis: Implications for automated systems. PLoS One 11(4): e0154032.doi:10.1371/journal.pone.0154032.

126. *Eisenbeis L, Gao Z, Heffernan C, Yacoub W, Long R, Verma G. Tuberculosis contact

investigation outcomes of Canadian-born adults by population group. Can J Public Health 2016; 107(1): e106-e111. doi: 10.17269/cjph.107.5255

127. Long R, Lau A. How R.G. Ferguson’s groundbreaking studies influenced our understanding of

tuberculosis reinfection: Where to next? Int J Tuberc Lung Dis 2016; 20: 1285-1287.

128. * Patel S, Paulsen C, Heffernan C, Saunders D, Christianson S, Sharma M, Wolfe J, Kunimoto D,

King M, Hoeppner V, Orr P, Menzies D, Boffa J, McMullin K, Lopez-Hille C, Senthilselvan S, Long,

R. Tuberculosis transmission in the Indigenous peoples of the Canadian Praires. PLoS One (Submitted).

129. Dehghani K, Lan Z, Robinson E, Soberg G, Picard J, Alvarez G, Cooper M, Long R, Menzies D. TB

trends and potential determinants in six Indigenous populations of North America and Greenland

from 1960-2014. Lancet Public Health (In preparation).

130. * Asadi L, Menzies D, Long R. Evaluating the effectiveness of Canada’s TB surveillance strategy in

identifying immigrants at risk of developing and transmitting TB? A population-based cohort study.

CMAJ (In preparation).

Book Chapters: 1. Long R. Critical illness due to Mycobacterium tuberculosis. In: Hall JB, Schmidt GA, Wood LDH,

eds. Principles of Critical Care Medicine. McGraw-Hill, 1989:1354-1360. 2. Long R. Tuberculosis in patients with human immunodeficiency virus infection. In: FitzGerald M,

ed. Canadian Tuberculosis Standards 4th ed. Toronto: University of Toronto Press, 1996;77-82.

3. Njoo H, Long R. The epidemiology of tuberculosis in Canada. In: Long R, ed. Canadian

Tuberculosis Standards 5th ed. Ottawa: Health Canada and Canadian Lung Association, 2000:3-14.

4. Long R, Jessamine P. Transmission and pathogenesis of tuberculosis. In: Long R, ed. Canadian

Tuberculosis Standards 5th ed. Ottawa: Health Canada and Canadian Lung Association, 2000:31-44.

5. Long R. Nonrespiratory (Extrapulmonary) Tuberculosis. In: Long R, ed. Canadian Tuberculosis

Standards 5th ed. Ottawa: Health Canada and Canadian Lung Association, 2000:67-81.

6. Long R, Avendano M. Drug-resistant tuberculosis. In: Long R, ed. Canadian Tuberculosis

Standards 5th ed. Ottawa: Health Canada and Canadian Lung Association, 2000:111-25. 7. Houston S, Schwartzman K, Brassard P, Avendano M, Long R. Tuberculosis in patients with

human immunodeficiency virus. In: Long R, ed. Canadian Tuberculosis Standards 5th ed. Ottawa: Health Canada and Canadian Lung Association, 2000:141-51.

CV: Richard Long

8. Long R, Schwartzman K. Transmission and pathogenesis of tuberculosis. In: Long R, Ellis E, eds.,

Canadian Tuberculosis Standards 6th edition. Ottawa: Health Canada and Canadian Lung Association, 2007: 37-52

9. Cook V, Long R. Non-respiratory tuberculosis. In: Long R, Ellis E, eds., Canadian Tuberculosis

Standards 6th edition. Ottawa: Health Canada and Canadian Lung Association, 2007: 92-113 10. Long R, Avendano M, Whitehead L. Drug-resistant tuberculosis. In: Long R, Ellis E, eds.,

Canadian Tuberculosis Standards 6th edition. Ottawa: Health Canada and Canadian Lung Association, 2007: 146-181

11. Kitai I, Malloy P, Kowalczyk A, Long R. Pediatric tuberculosis. In: Long R, Ellis E, eds. Canadian

Tuberculosis Standards 6th edition. Ottawa: Health Canada and Canadian Lung Association, 2007: 182-199

12. Long R, Schwartzman K. The Pathogenesis and Transmission of Tuberculosis. In Menzies D, ed.

Canadian Tuberculosis Standards, 7th edition., Ottawa. Canadian Lung Association and Public Health Agency of Canada, 2013.

13. Long R, Avendano M, Kunimoto D. Drug-resistant Tuberculosis. In Menzies D, ed. Canadian

Tuberculosis Standards, 7th edition, Ottawa. Canadian Lung Association and Public Health Agency of Canada, 2013.

14. Alvarez G, Orr P, Wobeser W, Cook V, Long R. Tuberculosis Prevention and Care in First Nations,

Inuit and Métis Peoples. In Menzies D, ed. Canadian Tuberculosis Standards, 7th edition, Ottawa. Canadian Lung Association and Public Health Agency of Canada, 2013.

Books:

1. Long R. ed. Canadian Tuberculosis Standards 5th ed. Ottawa: Health Canada and Canadian Lung Association, 2000.

2. Long R, Ellis E, eds. Canadian Tuberculosis Standards 6th ed. Ottawa: Health Canada and Canadian Lung Association, 2007.

3. Menzies D ed; Ellis E, Long R, Pai M, Wong T, Associate eds. Canadian Tuberculosis Standards

7th ed. Ottawa: Canadian Lung Association and Public Health Agency of Canada, 2013.

Educational Resources: 1. Long R, King M, Mayan M, Abonyi S, Hackett P, McMullin K, Heffernan C. Tuberculosis Education

for Aboriginal and non-Aboriginal Youth. 2012 Available at http://tbper.med.ualberta.ca/files/5313/3427/1441/Resource_Guide.pdf

Monographs, Letters, Etc.:

1. Long R, Hershfield E, Manfreda J. Politically correct language. CMAJ 1993; 149:799.

2. * Corne S, Long R. The War Against TB: Clues to Victory. (monograph) MEDICINE North

America March 1995;223-231.

http://tbper.med.ualberta.ca/files/5313/3427/1441/Resource_Guide.pdf

CV: Richard Long

3. Long R, Scalcini M, Ollé-Goig J. Treatment of tuberculosis in Haiti (letter). Am J Public Health 2001;91:1546-47.

4. Houston S, Long R, Hoeppner V. Latent tuberculosis treatment (letter). CMAJ 2002;167:5

5. Embil J, Long R. The trouble with tuberculosis! (monograph) Can J CME December, 2004;57-58.

6. Long R. Tuberculosis Surveillance Report Alberta 2005 to 2009 with Preliminary Summary 2010. A

Report by the office of the Chief Medical Officer of Health. 2012 Available at http://www.health.alberta.ca/documents/CMOH-TB-Alberta-2005-2009.pdf

7. Singh A, Long R. Responding to positive tuberculin tests in health care workers with a history of

BCG vaccination (Experts on call). Can J Diagnosis 2013; 30(6) http://cjdiagnosis.com/articles/tb-skin-tests-and-health-care-workers

8. Long R. Langlois-klassen D. A clinical opportunity for routine HIV testing. (letter) CMAJ 2013; 185(7): 587.

XXI ABSTRACTS PRESENTED AT REGIONAL, NATIONAL OR INTERNATIONAL MEETINGS

1. Sandoval J, Long R, Skoog C, Wood LDH, Oppenheimer L. Independent influence of blood flow

rate and mixed venous PO2 on shunt fraction. Canadian Society of Clinical Investigation, 1983. 2. Sandoval J, Long R, Skoog C, Wood LDH, Oppenheimer L. Independent influence of blood flow

rate and mixed venous PO2 on shunt fraction. Federation of the American Society for

Experimental Biology, 1983. 3. Sznajder I, Zucker A, Wood LDH, Long R. The effects of plasmapheresis and hemofiltration on

canine acid aspiration pulmonary edema. American College of Chest Physicians, 1984, Annual Cecil Lehman Mayer Award.

4. Mayers I, Long R, Breen P, Wood LDH. Artificial ventilation of a canine model of bronchopleural

fistula. Federation of the American Society for Experimental Biology, 1983. 5. Mayers I, Long R, Breen P, Wood LDH. Artificial ventilation of a canine model of bronchopleural

fistula. American Thoracic Society, 1983. 6. Breen PH, Becker LJ, Ruygrok P, Mayers I, Long R, Leff A, Wood LDH. Canine

bronchoconstriction, gas trapping and hypoxia with methacholine. Federation of the American

Society for Experimental Biology, 1983. 7. Breen PH, Becker LJ, Ruygrok P, Mayers I, Long R, Leff A, Wood LDH. Canine

bronchoconstriction, gas trapping and hypoxia with methacholine. American Thoracic Society, 1983.

8. Gottlieb SS, Wood LDH, Hansen DE, Long R. The effect of nitroprusside on pulmonary edema,

oxygen exchange and blood flow in hydrochloric acid aspiration. American Federation for Clinical

Research, 1984. 9. Gottlieb SS, Wood LDH, Hansen DE, Long R. The effect of nitroprusside on pulmonary edema,

oxygen exchange and blood flow in hydrochloric acid aspiration. American Thoracic Society, 1984.

http://www.health.alberta.ca/documents/CMOH-TB-Alberta-2005-2009.pdf

http://cjdiagnosis.com/articles/tb-skin-tests-and-health-care-workers

http://cjdiagnosis.com/articles/tb-skin-tests-and-health-care-workers

CV: Richard Long

10. Schumacker PT, Long R, Wood LDH. Tissue oxygen extraction during hypovolemia: role of

hemoglobin P50. Federation of the American Society for Experimental Biology, 1984. 11. Mayers I, Breen PH, Gottlieb S, Long R, Wood LDH. The effects of indomethacin on edema and

gas exchange in canine acid aspiration. American Physiologic Society, 1983. 12. Long R, Nelson D, Sznajder I, Wood LDH, Schumacker PT. Systemic oxygen delivery and

consumption during acute lung injury in dogs. Federation of the American Society for

Experimental Biology, 1984. 13. Long R, Nelson D, Sznajder I, Wood LDH, Schumacker PT. Systemic oxygen delivery and

consumption during acute lung injury in dogs. American Thoracic Society, 1984. 14. Long R, Breen PH, Mayers I, Wood LDH. Treatment of Canine acid aspiration pneumonitis: fluid

volume reduction vs fluid volume expansion. Federation of the American Society for

Experimental Biology, 1983. 15. Long R, Breen PH, Mayers I, Wood LDH. Treatment of Canine acid aspiration pneumonitis: fluid

volume reduction vs fluid volume expansion. American Thoracic Society, 1983. 16. Long R, Filuk R, Balakumar M, Easton PA, Anthonisen NR. Ventilatory response to sustained

hypoxia: effect of methysergide and verapamil. Federation of the American Society for

Experimental Biology, 1986. 17. Long R, Younes M, Patton N, Hershfield E. Tuberculous Pericarditis: long term outcome in

patients who received medical therapy alone. American Thoracic Society, 1987.

18. Long R, Scalcini M, Carre G, Jean-Baptiste M, Hershfield E, Parker S, Wolfe J, Nelz K.

Antituberculous drug resistance in central Haiti. American Thoracic Society, 1989.

19. Long R, Scalcini M, Carre G, Jean-Baptiste M, Hershfield E, Parker S, Wolfe J, Nelz K.

Antituberculous drug resistance in central Haiti. American Thoracic Society, 1990. 20. Long R, Scalcini M, Manfreda J, Carre G, Phillippe E, Hershfield E, Sekla L, Stackiw W. Impact of

human immunodeficiency virus type 1 on pulmonary tuberculosis in rural Haiti. American Thoracic

Society, 1990. 21. Long R, Maycher B, Scalcini M, Manfreda J. The chest radiograph in pulmonary tuberculosis

patients seropositive for human immunodeficiency virus type-1. American Thoracic Society, 1990.

22. Long R, Scalcini M, Occenac R, Manfreda J. Pulmonary tuberculosis, human immunodeficiency

virus type-1 infection and malnutrition. American Thoracic Society, 1990. 23. Long R, Scalcini M, Jean-Baptiste M, Manfreda J, Hershfield E. The impact of HIV on the

usefulness of sputum smears for the diagnosis of tuberculosis. American Thoracic Society, 1991. 24. Long R, Manfreda J, Mendella L, Parker S, Wolfe J, Hershfield E. Antituberculous drug resistance

in the Province of Manitoba (1980-89). World Congress on Tuberculosis, 1992.

25. Long, R, Scalcini M. Follow-up of HIV seropositive tuberculosis patients in rural Haiti. World

Congress on Tuberculosis, 1992.

CV: Richard Long

26. Long R, Maycher B, Dhar A, Manfreda J, Hershfield E, Anthonisen A. Pulmonary Tuberculosis

Treated with Directly Observed Therapy: Serial Changes in Lung Structure and Function.

American Thoracic Society, 1993. 27. Penner CG, Roberts D, Kunimoto D, Manfreda J, Long R. Tuberculosis as a primary cause of

respiratory failure requiring mechanical ventilation. American Thoracic Society, 1994. 28. Long R, Choudhri S, Manfreda J, Wolfe J, Parker S. Clinical Significance of the Isolation of

Nontuberculosis Mycobacteria in a Canadian Tertiary Care Centre. American Thoracic Society, 1994.

29. Palayew M, Long R, O'Connor R, Hershfield E, Manfreda J. Disseminated Tuberculosis With and

Without a Miliary Pattern on Chest Radiograph. American Thoracic Society, 1994. 30. Long R, Fanning A, Cowie R, Hoeppner V, FitzGerald M and the Western Canada Tuberculosis

Group. Antituberculous Drug Resistance in Western Canada (1993-94) American Thoracic

Society, 1995. 31. Chrusch C, Manfreda J, Long R, Hershfield E. Tuberculosis in St. Vincent and the Grenadines.

American Thoracic Society, 1995. 32. Fanning A, Long R, Cowie R, Hoeppner V, FitzGerald M and the Western Canada Tuberculosis

Group. Antituberculous Drug Resistance in Western Canada (1993-94). International Union

Against Tuberculosis and Lung Disease (North American Region), 1996. 33. Long R, Choudhri S, Hawken M, Gathua S, Minyiri GO, Watkins W, Sahai J, Sitar D, Aoki F. The

Pharmacokinetics of Antimycobacterial Drugs in Patients with Tuberculosis, AIDS and Diarrhea.

American Thoracic Society, 1996. 34. Choudhri S, Hawken M, Gathua S, Minyiri GO, Watkins W, Sahai J, Sitar D, Aoki F, Long R. The

Pharmacokinetics of Antimycobacterial Drugs in Patients with Tuberculosis, AIDS and Diarrhea. 6th

Annual Canadian Conference on HIV/AIDS Research, 1997. 35. Arvanitakis Z, Long R, Hershfield E, Manfreda J, Kabani A, Power C. M. tuberculosis Molecular

Variation in CNS Infection. Evidence of Strain Dependent Neurovirulence. American Academy of

Neurology, 1997. 36. Huzel L, Belisle J, Brennan P, Kunimoto D, Long R. Are M. tuberculosis Isolates from Critically Ill

Patients Associated with Identifiable "Virulence Factors"? American Thoracic Society, 1997. 37. Bahammamn A, Choudhri S, Long R. The validity of acid-fast smears of gastric aspirates as an

indicator of pulmonary tuberculosis. American Thoracic Society, 1997. 38. Arvanitakis Z, Long R, Hershfield E, Manfreda J, Kabani A, Power C. M. tuberculosis Molecular

Variation in CNS Infection. Evidence of Strain Dependent Neurovirulence. American Thoracic

Society, 1998. 39. Long R, Njoo H, Hershfield E. The Epidemiology of Tuberculosis in Canada: Implications for

Diagnosis and Treatment. American Thoracic Society, 1998.

CV: Richard Long

40. Guzman R, Long R, Greenberg H, Safneck J, Hershfield E. Tuberculous Mycotic Aneurysm of the

Aorta: Review of Published Medical and Surgical Experience. Annual Meeting Canadian Society

for Vascular Surgery, 1998. 41. Hersi A, Elwood K, Cowie R, Kunimoto D, Long R. Multidrug-Resistant Tuberculosis in Western

Canada (1989-98). Alberta Lung Association, 5th Annual Respiratory Disease Symposium, 1998.

42. Long R, Houston S, Raftery A, Manfreda J. Exploring the impact of HIV on tuberculosis in

Aboriginals in Alberta. IUATLD North American Region, Chicago, February, 1999. 43. Long R, Nobert E, Chomyc S, van Embden J, McNamee C, Rey Duran R, Talbot J, Fanning A.

Transcontinental Spread of Multidrug-resistant M. bovis. IUATLD North American Region, Chicago, February, 1999.

44. Long R, Houston S, Raftery A, Manfreda J. Exploring the impact of HIV on tuberculosis in

Aboriginals in Alberta. 1999 Tuberculosis Conference, Edmonton, March, 1999. 45. Long R, Nobert E, Chomyc S, van Embden J, McNamee C, Rey Duran R, Talbot J, Fanning A.

Transcontinental Spread of Multidrug-resistant M. bovis. 1999 Tuberculosis Conference, Edmonton, March 1999.

46. Long R, Talbot J, Light B. The mycobacteriocidal action of exogenous nitric oxide. American

Thoracic Society, San Diego, April, 1999. 47. Long R, Talbot J, Mayers I, Light B. Treatment of sputum-smear-positive pulmonary tuberculosis

with inhaled nitric oxide. American Thoracic Society, San Diego, April, 1999. 48. Hersi A, Elwood K, Cowie R, Kunimoto D, Long R. Multidrug-resistant tuberculosis in Alberta and

British Columbia (1989-98). American Thoracic Society, San Diego, April, 1999. 49. Hersi A, Elwood K, Cowie R, Kunimoto D, Long R. Multidrug-resistant tuberculosis in Alberta and

British Columbia (1989-98). Clin Invest Med 1999; 22:4-5.

50. Long R, Zielinski M, Kunimoto D, Manfreda J. The emergency room is a major point of contact of

tuberculosis patients with the healthcare system of industrialized countries. Research Revelations

2000, Edmonton, February 5, 2000.

51. Long R, Zielinski M, Kunimoto D, Manfreda J. The Emergency Room is a major point of contact of

tuberculosis patients with the health care system of industrialized countries. International Union

Against Tuberculosis and Lung Disease, North American Region, Vancouver, February 24-26, 2000.

52. Hersi A, Cowie R, Kunimoto D, Long R. Tuberculosis mortality in the province of Alberta, 1994-98.

International Union Against Tuberculosis and Lung Disease, North American Region, Vancouver, February 24-26, 2000.

53. Sutherland K, Zielinski M, Benjamin E, Cowie R, Kunimoto D, Long R. Local epidemiologic

determinants of TB prevention, control and elimination strategies in Alberta, Canada. International

Union Against Tuberculosis and Lung Disease, North American Region, Vancouver, February 24-26, 2000.

CV: Richard Long

54. Hersi A, Kunimoto D, Long R. Tuberculosis Mortality in the Province of Alberta, 1994-98. The Fifth

Annual Meeting of the Saudi Medical Trainees in Canada and USA, Montreal, March 18-19, 2000.

55. Long R, Zielinski M, Kunimoto D, Manfreda J. The Emergency Room is a major point of contact of

tuberculosis patients with the health care system of industrialized countries. American Thoracic

Society, Toronto, May 5-10, 2000. Thematic Poster Session: Tuberculosis Epidemiology. 56. Long R, Zielinski M, Kunimoto D, Manfreda J. The Emergency Room is a major point of contact of

tuberculosis patients with the health care system of industrialized countries. American Thoracic

Society, Toronto, May 5-10, 2000. Tuberculosis Public Health Poster Forum. 57. Long R, Chui L, Kakulphimp J, Zielinski M, Talbot J, Kunimoto D. The post-sanatorium pattern of

antituberculous drug resistance in the Canadian-born population of western Canada: effect of

outpatient care and immigration. American Thoracic Society, Toronto, May 5-10, 2000. 58. Yellow Horn P, Warrior H, Potts D, North-Peigan F, Day Chief C, Pettigrew L, Raftery A, Benjamin

E, Strong D, Long R. Peigan First Nations TB Elimination Project. American Thoracic Society, Toronto, May 5-10, 2000.

59. Hersi A, Kunimoto D, Long R. Tuberculosis mortality in the province of Alberta, 1994 to 1998. Clin

Invest Med 2000;23:199-216. 60. Long R, Zielinski M, Benjamin E, Senthilselvan A. The feasibility of short-course tuberculosis

preventative therapy in correctional centres in Alberta, Canada. International Union Against

Tuberculosis and Lung Disease, North American Region, Chicago, March 1-3, 2001. 61. Omeasoo N, Lightning I, Raine E, Yellowbird S, Roan R, Raftery A, Strong D, Clark M, Mercredi M,

Littlechild H, Goin L, Lafond T, Downie H, Benjamin E, Whittaker D, Ali S, Chorney S, Long R. First

Nations Community Planning for tuberculosis reduction. International Union Against

Tuberculosis and Lung Disease, North American Region, Chicago, March 1-3, 2001. 62. Long R, Zielinski M, Kunimoto D, Manfreda J. The Emergency Room is a major point of contact of

tuberculosis patients with the health care system of industrialized countries. Tuberculosis: Forging

the Streams. Edmonton, Alberta, March 22 and 23, 2001. 63. Long R, Zielinski M, Benjamin E, Senthilselvan A. The feasibility of short-course tuberculosis

preventative therapy in correctional centres in Alberta, Canada. Tuberculosis: Forging the

Streams. Edmonton, Alberta, March 22 and 23, 2001. 64. Yellow Horn P, Warrior H, Potts D, North-Peigan F, Day Chief C, Pettigrew L, Raftery A, Benjamin

E, Strong D, Long R. Peigan First Nations TB Elimination Project. Tuberculosis: Forging the

Streams. Edmonton, Alberta, March 22 and 23, 2001. 65. Omeasoo N, Lightening I, Raine E, Yellowbird S, Roan R, Raftery A, Strong D, Clark M, Mercredi

M, Littlechild H, Goin L, Lafond T, Downie H, Benjami E, Whittaker D, Ali S, Chorney S, Long R.

First Nations Community Planning for tuberculosis reduction. Tuberculosis: Forging the

Streams. Edmonton, Alberta, March 22 and 23, 2001.

CV: Richard Long

66. Adamko B, Befus B, Duszyk M, King M, Lacy P, Long R, Moqbel R, Radomski M, Vliagoftis H.

Pulmonary Research Group: Towards a Better Understanding of Lung Disease. Research

Revelations 2001, University of Alberta, March 24, 2001. 67. Long R, Light B, Talbot J, Mayers I, Jones R. Treatment of sputum smear-positive pulmonary

tuberculosis with inhaled nitric oxide. ATS 2001, San Francisco, The 97th International

Conference, May 18-23, 2001, San Francisco, California. 68. Long R, Sutherland K, Kunimoto D, Cowie R, Manfreda J. The epidemiology of tuberculosis among

foreign-born persons in Alberta, Canada, 1989-1998. ATS 2001, San Francisco, The 97th

International Conference, May 18-23, 2001, San Francisco, California. 69. Menzies D, Cowie B, Elwood K, Gardam M, Hershfield E, Heywood N, Long R, Njoo H, Wobeser

W. Comparison of inter and intra-reader agreement when reading overseas and Canadian

immigration chest x-rays. ATS 2001, San Francisco, The 97th International Conference, May 18-23, 2001, San Francisco, California.

70. Long R, Sutherland K, Kunimoto D, Cowie R, Manfreda J. The epidemiology of tuberculosis among

foreign-born persons in Alberta, Canada, 1989-1998. 2001, Occupational Health Nurses

Association, Alberta. May 28-30, 2001, Delta South Edmonton. 71. Kunimoto D, Salmon J, Nobert E, Fanning A, Tilley P, Long R. Potential infectivity of patients with

pulmonary tuberculosis on treatment. Canadian Infectious Disease Society meeting. February 29 – March 3, 2002, Banff, Alberta.

72. Kunimoto D, Sutherland K, Fanning A, Talbot J, Long R. The limited impact of active TB in foreign-

born persons on active TB in the Canadian-born population in Alberta, 1994-1998. ICAAC, September 27-29, 2002, San Diego, California.

73. Zielinski M, Benjamin E, Bochar K, Manfreda J, Long R. The correctional system history of adult

tuberculosis patients in a prairie province of Canada. 33rd IUATLD World Conference on Lung

Health. October 6-10, 2002, Montreal, Canada. 74. Long R, Bochar K, Barrie J, Tilley P. The mycobacteriologic response-to-optimal-treatment of high

bacillary burden respiratory tuberculosis. 33rd IUATLD World Conference on Lung Health. October 6-10, 2002, Montreal, Canada.

75. Aung S, Sutherland K, Elwood K, FitzGerald M, Manfreda J, Long R. Antituberculosis drug

resistance in HIV-infected, HIV-uninfected, and HIV-status-unknown tuberculosis patients in

western Canada. 33rd IUATLD World Conference on Lung Health. October 6-10, 2002, Montreal, Canada.

76. Ochs A. (Supervisors King M and Long R). The physical properties of sputum from patients with

respiratory tuberculosis. 35th Annual Summer Students Research Day, University of Alberta, October 19, 2002.

77. Long R, Sutherland K, Aung S, Kunimoto D, Elwood K, Fitzgerald M, Preiksaitis J, Hernandez E,

Stephens G, Manfreda J. Anti-tuberculosis drug resistance in HIV-infected, HIV-uninfected and

HIV-status unknown tuberculosis patients in western Canada. 4th Bi-annual Spring Conference,

Tuberculosis: Elimination or resurgence”. March 17-18, 2003, Edmonton, AB

CV: Richard Long

78. Long R, Bochar K, Chomyc S, Talbot J, Barrie J, Kunimoto D, Tilley P. Relative versus absolute

non-contagiousness of respiratory tuberculosis on treatment. 4th Bi-annual Spring Conference,

Tuberculosis: Elimination or resurgence”. March 17-18, 2003, Edmonton, AB 79. Kunimoto D, Sutherland K, Fanning A, Talbot J, Manfreda J, Long R. The limited effect of TB in

foreign-born persons on TB in Canadian-born persons in Alberta, 1994-98. 4th Bi-annual Spring

Conference, Tuberculosis: Elimination or resurgence”. March 17-18, 2003, Edmonton, AB 80. Chong H, Bochar K, Kunimoto D, Yacoub W, Manfreda J, Long R. The public health consequences

of smear-positive respiratory tuberculosis by ethnic groups in Alberta, 1998-2002. International

Union Against Tuberculosis and Lung Disease, North American Region. February 23-26, 2005, Vancouver, BC

81. Jacobs S, Warman A, Roehrig N, Yacoub W, Benjamin E, Chong H, Wijayasinghe C, Long R.

Systematic withdrawal of BCG (Bacille Calmette-Guérin) vaccine from First Nations in Alberta.

International Union Against Tuberculosis and Lung Disease, North American Region. February 23-26, 2005, Vancouver, BC

82. Webster D, Kowalewska-Grochowska K, Long R, Fanning A. Renal tuberculosis in northern

Alberta; a 30 year experience. International Union Against Tuberculosis and Lung Disease,

North American Region. February 23-26, 2005, Vancouver, BC 83. Lee MC, Takaya S, Long R, Joffe M. Qualitative fit testing does not ensure health care worker

respiratory protection. AMMI/CACMID, Association of Medical Microbiologists and Infectious

Diseases in Canada. April 14-17, 2005, Ottawa, ON

84. Lee MC, Takaya S, Long R, Joffe M. Qualitative fit testing does not ensure health care worker

respiratory protection. SHEA Society of Healthcare Epidemiology of America. April 9-12, 2005, Los Angeles, CA, USA

85. Kunimoto D, Der E, Beckon A, Cabrita L, Egedahl M, Alexander M, Shokoples S, Tyrrell G, Nobert

E, Fanning A, Brown N, Long R. Potential Impact of the Quantiferon® Blood Test for Latent TB

Infection in a Canadian TB Clinic. AMMI/CACMID, Association of Medical Microbiologists and

Infectious Diseases in Canada. April 14-17, 2005, Ottawa, ON 86. Yip D, Bhargava R, Yao Y, Kunimoto D, Chui L, Sutherland K, Manfreda J, Long R. Pediatric

tuberculosis: Molecular epidemiologic insights into the spatial and temporal pattern of disease in

western Canada, 1990-2004. The College of Family Physicians of Canada. December 8-11, 2005, Vancouver, BC.

87. Yip D, Bhargava R, Yao Y, Kunimoto D, Chui L, Sutherland K, Manfreda J, Long R. Pediatric

tuberculosis: Molecular epidemiologic insights into the spatial and temporal pattern of disease in

western Canada, 1990-2004. Fifth Spring Conference on Tuberculosis. The Edge of Change:

What’s New in an Old Disease. March 23 and 24, 2006. Edmonton, AB. 88. Kunimoto D, Der E, Becton A, Cabrita L, Egedahl M, Alexander M, Shokoples S, Tyrrell G, Ahmed

R, Brown N, Menzies D, Long R. Potential Impact of the Quantiferon ® TB Gold Blood Test in a

Canadian TB Clinic. 46th Annual ICAAC, Interscience Conference on Antimicrobial Agents and

Chemotherapy. September 29, 2006. San Francisco, USA.

89. King M, Boffa J, Long R. Conducting tuberculosis research with Aboriginal communities in

Western Canada according to the new ethical principles of Aboriginal health research. Intl Network

CV: Richard Long

Indigenous Health Knowledge Development, Rotorua New Zealand, Oct 2007.

90. Breton J, Bhutani M, Manfreda J, Long R. A population based study of post-treatment follow-up and

relapsed tuberculosis. 38th Union World Conference on Lung Health. Cape Town, South Africa. November 8-12, 2007.

91. Chui L, Long R, Tyrrell G, Preiksaitis J, Kunimoto D and the Molecular Diagnostic Team. A review

of molecular typing of TB isolates in Alberta. AMMI CANADA – CACMID Annual Conference

2008, February 27 to March 1, 2008, Vancouver, B.C. 92. Langlois–Klassen D, Kunimoto D, Saunders D, Chui L, Boffa J, Long R. The clinical and

epidemiological characteristics of Mycobacterium tuberculosis Beijing/W family strains in a major

immigrant receiving province of Canada. International Union against Tuberculosis and Lung

Disease – North American Region. February 28 – March 1, 2008, San Diego, CA, USA. 93. Dion MJ, Long R, Trajman A, Yang J, Al Jahdali H, Khan K, Gardam M, Wobeser W, Hoeppner V,

Cowie R, Schwartzman K, Menzies D. A randomized trial comparing adverse events with 4 RIF and

9 INH in the treatment of latent TB infection. American Thoracic Society Meeting, May 16-21, 2008, Toronto, ON.

94. Aspler A, Dion MJ, Long R, Trajman A, Yang J, Al Jahdali H, Khan K, Gardam M, Wobeser W,

Hoeppner V, Cowie R, Schwartzman K, Menzies D. Cost and cost effectiveness of a randomized trial of 4 months rifampin versus 9 months of isoniazid for treatment of latent tuberculosis infection

(LTBI). American Thoracic Society Meeting, May 16-21, 2008, Toronto, ON. 95. Hwang J, Puttagunta L, Green F, Stollery D, Barrie J, Ramesh W, Long R.

Bronchialanthrocofibrosis and tuberculosis in immigrants to Canada from the Indian subcontinent.

Canadian Association of Pathologists, July 12-16, 2008. Ottawa, ON. 96. Olsen S, Long R, Tyrrell G, Kunimoto D. Utilization of induced sputum and bronchoscopy for

diagnosis of pulmonary tuberculosis. American College of Chest Physicians Meeting, October 25-30, 2008, Philadelphia, PA.

97. Langlois-Klassen D, Wooldrage K, Manfreda J, Ellis E, Phypers M, Gushulak B, Long R. Why are

tuberculosis case numbers and rates unchanging among foreign-born persons in Canada?

International Union Against Tuberculosis and Lung Disease North American Region Meeting, February 26 – 28, 2009, Vancouver, BC.

98. Langlois-Klassen D, Wooldrage K, Manfreda J, Ellis E, Phypers M, Gushulak B, Long R. Treatment

of Latent Tuberculosis Infection in Recently Arrived Immigrants to Canada. International Union

Against Tuberculosis and Lung Disease North American Region Meeting, February 26 – 28, 2009, Vancouver, BC.

99. McMullin K, Lopez-Hille C, Boffa J, Mayan M, Long R, King M, Orr P, Hoeppner V, Abonyi S. A

Prairie-wide Approach to the Study of TB Transmission in Canada. International Union Against

Tuberculosis and Lung Disease North American Region Meeting, February 26 – 28, 2009, Vancouver, BC.

100. Boffa J, Yacoub W, Kunimoto D, Chui L, Long R. The Conventional and Molecular Epidemiology of

Tuberculosis in On-Reserve and Off-Reserve First Nations in Alberta. International Union Against

Tuberculosis and Lung Disease North American Region Meeting, February 26 – 28, 2009, Vancouver, BC.

CV: Richard Long

101. Langlois-Klassen D, Wooldrage K, Manfreda J, Ellis E, Phypers M, Gushulak B, Long R. Treatment

of Latent Tuberculosis Infection in Recently Arrived Immigrants to Canada. CSEB/APHEO 2009

Joint Conference Meeting, May 25-28, 2009, Ottawa, ON, Canada

102. Langlois-Klassen D, Wooldrage K, Manfreda J, Ellis E, Phypers M, Gushulak B, Long R. Why are Tuberculosis Case Numbers and Incidence Rates Unchanging among Foreign-born Persons in

Canada? CSEB/APHEO 2009 Joint Conference Meeting, May 25-28, 2009, Ottawa, ON, Canada

103. Lopez C, Long R, Boffa J, McMullin K, Mayan M, Abonyi S, Orr P. The Determinants of Tuberculosis Transmission in the Canadian-Born Population of the Prairie Provinces: The

Qualitative Findings. 14th International Congress on Circumpolar Health Meeting, July 11-16, 2009, Yellowknife, NWT, Canada.

104. Long R, Lau A, Barrie J, Winter C, Kunimoto D, Elamy H, Tyrrell G. The public health

consequences of smear positive pulmonary tuberculosis in patients with typical and atypical chest

radiographs. 42nd Annual Summer Student Research Day, October 17, 2009. Recall Center for Pharmacy and Health Research, Edmonton, Alberta.

105. Jacobs S, Warman A, Richardson R, Yacoub W, Angela Lau, Whittaker D, Cockburn S, Verma G,

Boffa J, Lau A, Tyrrell G, Kunimoto D, Manfreda J, Long R. The isolated effect of BCG (bacille Calmette-Guérin) vaccination in infancy on tuberculin reactivity in grade 1 and grade 6 school

children: confirmatory testing using the Quantiferon test. International Union Against

Tuberculosis and Lung Disease. North American Region Meeting March 11-13, 2010. Orlando, FL, USA.

106. Jacobs S, Warman A, Richardson R, Yacoub W, Angela Lau, Whittaker D, Cockburn S, Verma G,

Boffa J, Lau A, Tyrrell G, Kunimoto D, Manfreda J, Long R. The isolated effect of BCG (bacille Calmette-Guérin) vaccination in infancy on tuberculin reactivity in grade 1 and grade 6 school

children: confirmatory testing using the Quantiferon test. 7th Biennial Tuberculosis Conference –

Stop TB yes we can. Edmonton, AB, March 25-26, 2010

107. Langlois-Klassen D, Kunimoto D, Saunders D, Boffa J, Long R. Beijing/W family Mycobacterium

tuberculosis in a major immigrant-receiving country: an emerging public health threat? 14th

International Congress on Infectious Disease. March 9-12, 2010, Miami, Florida, USA

108. Langlois-Klassen D, Kunimoto D, Saunders D, Boffa J, Long R. Beijing/W family Mycobacterium

tuberculosis in a major immigrant-receiving country: an emerging public health threat? 7th Alberta

Respiratory Disease Symposium (ARDS) April 8-11, 2010 Banff, Alberta.

109. Abdel-Halim Elamy, Mrinal Mandal, Behrouz Far, Anup Basu, Irene Cheng, and Richard Long. An Intelligent CAD System for Automated Detection of Pulmonary Tuberculosis on Chest Radiograph

and CT Thorax: A Road Map. Paper 1569877319 23rd IEEE Canadian Conference on Electrical

and Computer Engineering (CCECE-10) May 2, 2010 Calgary, Alberta

110. Abdel-Halim Elamy, Behrouz Far, and Richard Long. A Multiagent System for Automated Detection

and Diagnosis of Active Tuberculosis on Chest Radiograph and CT Thorax. Paper 285 22nd

International Conference on Software Engineering and Knowledge Engineering (SEKE2010). July 2010, San Francisco, California, USA

111. Boffa J, Mayan M, McMullin K, Lopes-Hille C, Long R, Abonyi S. Restoring balance: Perspectives

on health and disease amongst Aboriginal TB Patients on the Canadian Prairies. 20th IUHPE World

Conference on Health Promotion, July 11–15, 2010. Geneva, Switzerland

CV: Richard Long

112. Langlois-Klassen D, Kunimoto D, Saunders D, Chui L, Boffa J, Long R. Beijing/W family of Mycobacterium tuberculosis in a major immigrant receiving country: an emerging health threat?

European Respiratory Society Annual Congress, September 18-22, 2010 Barcelona, Spain

113. Langlois-Klassen D, Kunimoto D, Saunders D, Chui L, Boffa J, Long R. Are Beijing/W strains an

emerging public health threat in a major immigrant recruiting country? 41st Union World

Conference on Lung Health, November 11-15, 2010. Berlin, Germany

114. Lau A, Jacobs S, Warman A, Richardson R, Yacoub W, Whittaker D, Cockburn S, Verma G, Boffa J, Tyrrell G, Kunimoto D, Manfreda J, Long R. The Tuberculosis skin test is unreliable in low risks

bacille Calmette-Guérin (BCG) - vaccinated school children. 2010 Rising Star of Research

Competition at UBC, August 18-22nd, Vancouver, BC

115. Jensen, M, Lau A, Langlois-Klassen D, Boffa J, Manfreda J, Long R. Tuberculosis in Alberta:

Implication of Epidemiological Trends for Disease Elimination. Faculty of Medicine and Dentistry

43rd Annual Summer Student Research Day, October 16, 2010, Edmonton, AB

116. Lau A, Jacobs S, Warman A, Richardson R, Yacoub W, Whittaker D, Cockburn S, Verma G, Boffa J, Tyrrell G, Kunimoto D, Manfreda J, Long R. The Tuberculosis skin test is unreliable in low risks

bacille Calmette-Guérin (BCG) - vaccinated school children. Faculty of Medicine and Dentistry

43rd Annual Summer Student Research Day, October 16, 2010, Edmonton, AB

117. Varughese, M, Li M, Langlois-Klassen D, Long R. Latent Tuberculosis (TB) in Canada 1986-2002

and Beyond. MITACS/CORS Annual Conference 2010, May 25-27, 2010, Edmonton, AB.

118. Varughese, M, Li M, Langlois-Klassen D, Long R. Latent Tuberculosis (TB) in Canada 1986-2002

and Beyond. IGTC Research Summit, October 1 -3, 2010, Kelowna, BC.

119. Boffa J. Rollins G, McMullin K, Abonyi S, Long R. Canada’s Global Health Crisis: TB Knowledge,

Attitudes, and Practices Amongst First Nations Youth. Canadian Conference on Global Health. October 31- November 3, 2010. Ottawa, Ontario.

120. Langlois-Klassen D, Kunimoto D, Saunders D, Chui L, Boffa J, Long R. Mycobacterium tuberculosis

Beijing/W strain family: an emerging public health threat in a major immigrant-receiving country?

International Union Against Tuberculosis and Lung Disease North American Region Meeting, February 24 – 26, 2011, Vancouver, BC.

121. Grant J, Abonyi S, Park J, Long R The Determinants of TB Transmission among Indigenous

Peoples in Canada International Union Against Tuberculosis and Lung Disease North

American Region Meeting, February 24 – 26, 2011, Vancouver, BC. 122. Lau A, Barrie J, Winter C, Kunimoto D, Elamy H, Tyrrell G, Long R. The Public Health

consequences of smear positive pulmonary tuberculosis in patients with typical vs. atypical chest

radiographs. International Union Against Tuberculosis and Lung Disease North American

Region Meeting, February 24 – 26, 2011, Vancouver, BC.

123. Heffernan C, McMullin K, Abonyi S, Mayan M, King M, Boffa J, Long R. Baseline needs assessment

of TB education in Aboriginal Youth. International Union Against Tuberculosis and Lung

Disease North American Region Meeting, February 24 – 26, 2011, Vancouver, BC.

124. McMullin K, Abonyi S, Mayan M, Long R. Evoking ‘Old Keyam’: TB transmission and over-

representation of Prairie indigenous people. International Union Against Tuberculosis and Lung

Disease North American Region Meeting, February 24 – 26, 2011, Vancouver, BC.

CV: Richard Long

125. Fontaine J, Ramsing R, Junker A, Yacoub W, Langley JM, Embree J, Schultz K, Grenier D, Long R.

Severe combined immunodeficiency syndrome (SCID) in First Nations and Inuit in Canada –

implications for BCG vaccination. International Union Against Tuberculosis and Lung Disease

North American Region Meeting, February 24 – 26, 2011, Vancouver, BC.

126. Abonyi S, Mayan, M, McMullin K, Long R. Sick Enough to Seek Medical Attention: Tipping Points in

the Tuberculosis Experience of Aboriginal Peoples of the Canadian Prairies. Society for Applied

Anthropology – 71st Annual Meeting, March 29 – April 2, 2011, Seattle, Washington.

127. Varughese M, Li M, Langlois-Klassen D, Long R. Modeling the Dynamics of Latent TB in Canada

and Evaluation Intervention Strategies for TB Control. 8th PIMS Young Researchers Conference, May 2-5, 2011 Vancouver, Canada.

128. Lau A, Barrie J, Winter C, Kunimoto D, Elamy H, Tyrrell G, Long R. The public health

consequences of smear-positive pulmonary tuberculosis in patients with typical and atypical chest

radiographs. Department of Medicine Research Day, May 19th, 2011, University of Alberta, Edmonton.

129. Dhawan V, Lau A, Bhargava R, Kunimoto D, Long R. Use of population-based conventional and

molecular data in pediatric TB to understand TB transmission. Department of Medicine Research

Day, May 19th, 2011, University of Alberta, Edmonton.

130. Varughese M, Li M, Langlois-Klassen D, Long R. Latent Tuberculosis in Canada 1986-2002 and

Beyond. The 5th Geoffrey J. Butler Memorial Conference on Differential Equations and

Population Biology, July 25-30, 2011 Edmonton, Canada.

131. World L, Heffernan C, Long R. Wellness, social determinants of health and tuberculosis in First

Nations communities on the Canadian Prairies. Faculty of Medicine and Dentistry 44th Annual

Summer Student Research Day, October 15, 2011, Edmonton, AB.

132. Lau A, Barrie J, Winter C, Kunimoto D, Elamy H, Tyrrell G, Long R. The public health consequences of smear-positive pulmonary tuberculosis in patients with typical and atypical chest

radiographs. Third Annual Leader in Medicine Research Symposium University of Calgary, November 4, 2011, Calgary AB

133. Langlois-Klassen D, Wooldrage K, Manfreda J, Ellis E, Phypers M, Gushulak B, Long R. Novel

perspectives on foreign-born tuberculosis: trends, targets and transmission. School of Public

Health Insights Conference. Lister Hall, University of Alberta, Edmonton. November 16, 2011

134. Moffatt J, Mayan M, Long R. “Taking Care of Our Own”: The multifaceted relationship between on-

reserve having and tuberculosis (TB) occurrence. Pulmonary Research Day 2011, Department of Medicine, University of Alberta, November 16, 2011.

135. Jacobs S, Warman A, Richardson R, Yacoub W, Lau A, Langlois-Klassen D, Long R. Tuberculosis contact tracing and surveillance after discontinuation of BCG in on-reserve First Nations preschool

children in Alberta, Canada. 16th Annual Conference of The North American Regional Meeting

of the International Union Against TB and Lung Disease, Crown Plaza Hotel Riverwalk, San Antonio, TX, USA February 23-25, 2012

CV: Richard Long

136. Jacobs S, Warman A, Richardson R, Yacoub W, Lau A, Langlois-Klassen D, Long R. Tuberculosis contact tracing and surveillance after discontinuation of BCG in on-reserve First Nations preschool

children in Alberta, Canada. 8th Tuberculosis Symposium 2012, Coast Edmonton Plaza Hotel, Edmonton Alberta, March 22-23, 2012

137. Varughese M, Langlois-Klassen D, Long R, Li M. Using Mathematical Modeling to Evaluate an

Intervention Aimed at Preventing Tuberculosis in the Foreign-Born Population in Canada. 8th

Tuberculosis Symposium 2012, Coast Edmonton Plaza Hotel, Edmonton Alberta, March 22-23, 2012

138. Moffatt J, Mayan M, long R. Community-based participatory research to engage with marginalized

populations: the reflections of a PhD student. University of Alberta's Faculty of Extension

Research Showcase 2012, Corbett Hall, University of Alberta, Edmonton, Alberta May 25, 2012.

139. Moffatt J, Mayan M, Long R. “Taking Care of Our Own”: The multifaceted relationship between on-

reserve housing and tuberculosis (TB) occurrence. Canadian Public Health Association CPHA

Annual Conference 2012. Shaw Conference Centre, Edmonton, AB. June 11-14, 2012

140. Heffernan C, McMullin K, Long R. TB Education for Aboriginal and Non-Aboriginal youth. TB

Education and Training Network (TB ETN), Twelfth Annual Conference and TB Program

Evaluation Network (TB PEN), Fourth Annual Conference. Atlanta, Georgia, September 18-20, 2012.

141. Lau A, Barrie J, Winter C, Kunimoto D, Elamy H, Tyrrell G, Long R. The public health

consequences of smear-positive pulmonary tuberculosis in patients with typical and atypical chest

radiograph. The Canadian Society for Clinical Investigation Young Investigation forum. National Arts Centre, Ottawa, Ontario, September 19-21, 2012

142. Patel S, Heffernan C, Sharma M, Wolfe J, Long R. The association between tuberculosis and the

socio-economic status of First Nations in Manitoba. The Faculty of Medicine and Dentistry,

University of Alberta, 45th Annual Summer Students Research. October 13th, 2012, Edmonton, AB.

143. Long R, Hoeppner V, Orr P, Ainslie M, King M, Abonyi S, Mayan M, Kunimoto D, Langlois-Klassen

D, Heffernan C, Lau A, Menzies D. Marked disparity in TB on the Prairies among Aboriginal

Peoples. TB: Making a difference. Ontario Lung Association, November 19-20, 2012. Toronto, ON.

144. Heffernan C, McMullin K, Long R. TB Education for Aboriginal and non-aboriginal youth. TB:

Making a difference. Ontario Lung Association, November 19-20, 2012. Toronto, ON

145. Varughese B, Long R, Li M. Modeling Tuberculosis Transmission in Aboriginal Communities in the

Prairie Provinces: Linking Social Determinants to Transmission and Diagnosis Delay. IGTC

Summit. October 12-14, 2012. Kelowna, BC.

146. Varughese B, Langlois-klassen D, Long R, Li M. Preventing Tuberculosis in the Foreign-born

Population of Canada: A Mathematical Modeling Study. Centre for Disease Modeling Workshop-

Public Health Agency Workshop- Tuberculosis in Canada: Detection, Intervention, and

Compliance. November 14-15, 2012. Ottawa, ON.

CV: Richard Long

147. Courtemanche J, Garcia D, Long R, Rees S, Coady A. Health Canada’s Strategy Against

Tuberculosis for First Nations On-reserve. 17th Annual Conference of the North American

Regional Meeting of the International Union Against Tuberculosis and Lung Disease. February 28- March 1, 2013. Vancouver, BC.

148. Langlois-Klassen D, Long R. Increase Multi-drug Resistant Tuberculosis (MDR-TB) in Alberta

among Foreign-born Persons: Implications for Tuberculosis Management. 17th Annual Conference

of the North American Regional Meeting of the International Union Against Tuberculosis and

Lung Disease. February 28- March 1, 2013. Vancouver, BC.

149. Heffernan C, McMullin K, Long R. TB Education for Aboriginal and Non-Aboriginal youth (oral and

poster presentation). 17th Annual Conference of the North American Regional Meeting of the

International Union Against Tuberculosis and Lung Disease. February 28- March 1, 2013. Vancouver, BC.

150. Long R, Hoeppner V, Orr P, Ainslie M, King M, Abonyi S, Mayan M, Kunimoto D, Langlois-Klassen

D, Heffernan C, Lau A, Menzies D. Marked disparity in the epidemiology of tuberculosis among

Aboriginal peoples on the Canadian prairies: the challenges and opportunities. 17th Annual

Conference of the North American Regional Meeting of the International Union Against

Tuberculosis and Lung Disease. February 28- March 1, 2013. Vancouver, BC.

151. McMullin K, Abonyi S, Mayan M, Orr P, Lopez-Hille C, King M, Boffa J, Long R. Old Keyam – A framework for examining the disproportionate experience of tuberculosis among Aboriginal Peoples

of the Canadian Prairies (oral and poster presentation). 17th Annual Conference of the North

American Regional Meeting of the International Union Against Tuberculosis and Lung

Disease. February 28- March 1, 2013. Vancouver, BC.

152. Lamer T, Varughese M, Long R, Li M. Understanding TB Transmission in Alberta (Preliminary

results). WISEST (Women in Scholarship, Engineering, Science and Technology) Summer

Research Program. University of Alberta, August 14, 2013, Edmonton, AB

153. Varughese B, Long R, Li M. Modeling tuberculosis transmission in Aboriginal communities on the Canadian Prairies. Mathematical modeling of Indigenous Population Health Workshop. September 28-29, 2013. Banff, Alberta.

154. Varughese B, Langlois-Klassen D, Long R, Li M. Preventing Tuberculosis in the Foreign-born

population of Canada: A mathematical modeling study. 44TH Union World Conference on Lung

Health. October 30 – November 3, 2013. Paris, France.

155. Carew M, Wobeser W, Gordon J, Dasno P, Gleland A, Dignan T, Kielstra L, Daly K, Gatali M, Wilson S, Long R. Evaluation of BCG vaccine in an indigenous population in Northwestern Ontario.

18th Annual Conference of the North American Regional Meeting of the International Union

Against Tuberculosis and Lung Disease. February 27- March 1, 2014, Boston, MA.

156. Mah A, Kharrat H, Ahmed R, Gao Z, Der E, Hansen E, Long R, Kunimoto D, Cooper R. Serum drug levels of isoniazid and rifampin as a predictor of 2-month sputum culture results in patients with

tuberculosis. 18th Annual Conference of the North American Regional Meeting of the

International Union Against Tuberculosis and Lung Disease. February 27- March 1, 2014, Boston, MA.

CV: Richard Long

157. Patel S, Heffernan C, Saunders LD, Gao Z, Long R. Demographic and geographic characteristics of tuberculosis (TB) transmission in the Aboriginal peoples of Alberta and Saskatchewan, Canada.

The 2014 Mycobacterium Tuberculosis Summit. March 24-26, 2014. The O2, London, UK.

158. Paulsen C, Saunders D, Heffernan C, Patel S, Hoeppner V, Long R. Risks factors for pediatric

tuberculosis infection and disease following exposure to adult source cases on the prairies. Public

Health 2014. May 26-29, 2014, Toronto, Canada

159. Daly K, Wilson S, Carew M, Gordon J, Dasno P, Cleland A, Gatali M, Bellerose M, Dignan T, Muchenje V, Wobeser W, Farrel T, Bontovics E, Long R. An evaluation of the need for routine Bacille Calmette – Guérin (BCG) vaccine use among First Nations Infants in Northern Ontario.

Public Health 2014, May 26-29, 2014, Toronto, Canada

160. Patel S, Heffernan C, Saunders LD, Gao Z, Long R. Demographic and geographic characteristics of tuberculosis (TB) transmission in the Aboriginal peoples of Alberta and Saskatchewan, Canada.

Department of Medicine Research Day. May 15, 2014. University of Alberta. Edmonton, Alberta

161. Heffernan C, Varghese B, Long R. Homology of TB Fingerprints in the Canadian Prairies.

Implications for programming. Department of Medicine Research Day. May 15, 2014. University of Alberta, Edmonton, AB

162. Parhar A, Gao Z, Heffernan C, Ahmed R, Egedahl M, Long R. Is early tuberculosis death

associated with increased tuberculosis transmission? A case-control study in Canada. 45th Union

World Conference on Lung Health, 28th October – 1st November, 2014, Barcelona, Spain

163. Parhar A, Gao Z, Heffernan C, Gallant V, Ahmed R, Egedahl M, Long R. Prognostic factors

associated with tuberculosis death: a population-based study in Canada. 45th Union World

Conference on Lung Health, 28th October – 1st November, 2014, Barcelona, Spain

164. Christianson S, Sharma M, Wolfe J, Long D, Zhou H, Gao Z, Heffernan C, Long R. Molecular detection of isoniazid resistance in a Canadian province with a low incidence of antibiotic-resistant

tuberculosis. 45th Union World Conference on Lung Health, 28th October – 1st November, 2014, Barcelona, Spain

165. Heffernan C, Varughese M, Long R. Homology of TB fingerprint results on the Canadian Prairies:

Implications for programming. TB: Rising to the Challenges, November 18th and 19th, 2014. Toronto, Canada.

166. Komarnisky S, Hackett P, Heffernan C, Abonyi S, Mayan M, Long R. “Years Ago”: Evoking the past

in Indigenous patient narratives of tuberculosis. TB: Rising to the Challenges, November 18th and 19th, 2014. Toronto, Canada.

167. Patel S, Heffernan C, Long R. Predictors of Tuberculosis Transmission in 2007-2008: A Canadian-

born, Prairie-wide study. INSIGHTS: Focus on Public Health, School of Public Health, University of Alberta, November 12, 2014.

168. Heffernan C, Varughese B, Long R, Wolfe J, Sharma M, Christianson S. Homology of TB

Fingerprints in the Canadian Prairies. Implications for programming. 18th Annual Conference of

the North American Regional Meeting of the International Union Against Tuberculosis and

Lung Disease. February 26-28, 2015. Vancouver, BC.

CV: Richard Long


in Indigenous patient narratives of tuberculosis. 18th Annual Conference of the North American

Regional Meeting of the International Union Against Tuberculosis and Lung Disease. February 26-28, 2015. Vancouver, BC.

170. Eisenbeis L, Long R, Gao Z, Yacoub W, Verma G. “Predicting successful contact investigations for

Canadian-born Aboriginal and Non-aboriginal Tuberculosis Cases in Alberta”. 18th Annual

Conference of the North American Regional Meeting of the International Union Against

Tuberculosis and Lung Disease. February 26-28, 2015. Vancouver, BC.

171. Zhou H, Long D, Gao Z, Christianson S, Sharma M, Wolfe J, Heffernan C, Long R. “The Infectiousness and/or Virulence of Isoniazid-Resistant vs. Susceptible Pulmonary Tuberculosis: A

Case-Control Study in Canada. 18th Annual Conference of the North American Regional

Meeting of the International Union Against Tuberculosis and Lung Disease. February 26-28, 2015. Vancouver, BC.

172. Zhou H, Long D, Gao Z, Christianson S, Sharma M, Wolfe J, Heffernan C, Long R. “The

Infectiousness and/or Virulence of Isoniazid-Resistant vs. Susceptible Pulmonary Tuberculosis: A

Case-Control Study in Canada”. AMMI Canada – CACMID. April 16-18, 2015. Charlottetown, PEI.

173. Long R, Heffernan C, Cooper R, et al. Implementing the Patient’s Charter of Tuberculosis Care in

High Incidence Communities and Across Jurisdictional Borders. Pathways to Health Equity for

Aboriginal Peoples. Pathways Annual Gathering: Building Relationships for Moving Forward

Together. March 23-25, 2015. Ottawa, Ontario.

174. Komarnisky S, Heffernan C, Hackett P, Abonyi S, Mayan M, Varughese M, Long R. Informing

Strategies Against Tuberculosis for Indigenous Peoples of the Canadian Prairies. Pathways to

Health Equity for Aboriginal Peoples. Pathways Annual Gathering: Building Relationships

for Moving Forward Together. March 23-25, 2015. Ottawa, Ontario.


in Indigenous patient narratives of tuberculosis. Inner City Health and Wellness Symposium. Robbins Learning Centre, Royal Alexandra Hospital. June 22, 2015. Edmonton, Alberta.

176. Dehghani K, Lan Z, Robinson E, Soborg G, Picard J, Alvarez G, Cooper M, Long R. Trends of TB and potential determinants of TB in six indigenous populations of North America and Greenland

from 1960-2014. The 46th Union World Conference on Lung Health. December 2-6, 2015. Cape Town, South Africa.

177. Quach K, Heffernan C, Egedahl M, Saunders D, Long R. Clinical laboratory and outcome characteristics of foreign-born pulmonary tuberculosis patients by immigration status, Alberta, 2004-

2013. Insights: Focus on Public Health. October 28, 2015. Edmonton, Alberta.

178. Komarnisky S. Dark History: Indigenous residents and Alberta TB hospitals. Open Minds 2015, A

Celebration of Humanities and Social Sciences Research at the University of Alberta, November 4 2015. Education North 2-115, University of Alberta. Edmonton, Alberta.

179. Lau A, Barrie J, Winter C, Elamy A-H, Tyrrell G, Long, R. Maximizing the public health utility of

computer-aided detection systems for pulmonary tuberculosis. 20th Annual Conference of the

North American Regional Meeting of the International Union Against Tuberculosis and Lung

Disease. February 24-27, 2016 Denver, CO.

CV: Richard Long

180. Doroshenko A, Pepperell C, Heffernan C, Egedahl M-L, Smith T, Tyrrell G, Long R. The relative contribution of source case, contacts, environment and pathogen in tuberculosis outbreaks in First

Nations communities in Alberta, Canada. 20th Annual Conference of the North American

Regional Meeting of the International Union Against Tuberculosis and Lung Disease. February 24-27, 2016 Denver, CO.

181. Komarnisky S, NoKoHoo M, Piche D, Heffernan C, Long R. Pathways to Health Equity across

Jurisdictional Boundaries: Building a Team and Crafting Interventions. Transforming Health Care

in Remote Communities Conference, School of Public Health, University of Alberta,

Edmonton, Alberta. April 28-30. Chateau Lacombe Hotel, Edmonton, Alberta. 182. Heffernan C, Doroshenko A, Egedahl ML, Senthilselvan A. A Clinical Heuristic to Determine the

likelihood of Typical Adult-type Pulmonary Tuberculosis. Department of Medicine Research Day. May 19, 2016, Edmonton, Alberta.

183. Quach K, Heffernan C, Egedahl ML, Saunders LD, Long R. Clinical laboratory and treatment

outcome Characteristics of foreign-born tuberculosis patients in Alberta by immigration status,

2004-2013. Department of Medicine Research Day. May 19, 2016, Edmonton, Alberta.

184. Quach K, Heffernan C, Egedahl ML, Saunders LD, Long R. TB Elimination: Back to Basics. Ontario

Lung Association. November 15-16, 2016, Toronto, Ontario.

185. Varughese M, Plitt S, Heffernan C, Long R, Li M. Risk factors for delay in diagnosis of pulmonary

tuberculosis in Indigenous peoples on the Canadian prairies. 21st Annual Conference: The Union

– North America Region. February 23-25, 2017, Vancouver, BC.

186. Warrington P, Tyrrell G, Choy K, Eisenbeis L, Long R, Cooper R. Prevalence of latent tuberculosis

infection in Syrian refugees to Canada. 21st Annual Conference: The Union – North America

Region. February 23-25, 2017, Vancouver, BC.

187. Asadi L, Menzies D, Heffernan C, Long R. How effective is Canada’s TB surveillance strategy in identifying immigrants at risk of developing and transmitting TB? A population-based cohort study.

21st Annual Conference: The Union – North America Region. February 23-25, 2017, Vancouver, BC.

Update: April, 2001 · 2009 Outstanding Service Award, International Union Against Tuberculosis and...

Documents

Transcript of Update: April, 2001 · 2009 Outstanding Service Award, International Union Against Tuberculosis and...